Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
  • Curriculum.
  • Publikationen.
  • Projekte.
  • Patentanm./Patente.
  • Präsentationen.
  • Betreute Dipl u. Diss.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Samonigg Hellmut |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2019

Originalarbeit (Zeitschrift)

** Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria A cross-sectional multicentre observational study
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00542-7 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

2018

Originalarbeit (Zeitschrift)

** Stanzer, S; Andritsch, E; Zloklikovits, S; Ladinek, V; Farkas, C; Augustin, T; Obermayer-Pietsch, B; Samonigg, H; Bauernhofer, T A Pilot Randomized Trial Assessing the Effect of a Psychoeducational Intervention on Psychoneuroimmunological Parameters Among Patients With Nonmetastatic Breast Cancer.
Psychosom Med. 2018; 81(2):165-175 Doi: 10.1097/PSY.0000000000000656
Web of Science PubMed FullText FullText_MUG

 

2017

Originalarbeit (Zeitschrift)

** Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
PLoS One. 2017; 12(4):e0176283-e0176283 Doi: 10.1371/journal.pone.0176283 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691 Doi: 10.21873/anticanres.11617 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Fitzal, F; Filipits, M; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Dubsky, P; Bartsch, R; Kronenwett, R; Gnant, M The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Br J Cancer. 2015; 112(8):1405-1410 Doi: 10.1038/bjc.2015.98 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kandioler, D; Mittlböck, M; Kappel, S; Puhalla, H; Herbst, F; Langner, C; Wolf, B; Tschmelitsch, J; Schippinger, W; Steger, G; Hofbauer, F; Samonigg, H; Gnant, M; Teleky, B; Kührer, I; p53 Research Group and the Austrian Breast and Colorectal Study Group (ABCSG) TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
EBioMedicine. 2015; 2(8):825-830 Doi: 10.1016/j.ebiom.2015.06.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Reitz, D; Gerger, A; Seidel, J; Kornprat, P; Samonigg, H; Stotz, M; Szkandera, J; Pichler, M Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.
J Clin Pathol. 2015; 68(6):427-433 Doi: 10.1136/jclinpath-2014-202451
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Stiegelbauer, V; Winter, E; Schwarzenbacher, D; Kiesslich, T; Lax, S; Jahn, S; Deutsch, A; Bauernhofer, T; Ling, H; Samonigg, H; Gerger, A; Hoefler, G; Pichler, M MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
Mol Carcinog. 2015; 54(11):1442-1450 Doi: 10.1002/mc.22218
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Szkandera, J; Stojakovic, T; Seidel, J; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Seggewies, F; Hoefler, G; Gerger, A; Pichler, M The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Clin Chem Lab Med. 2015; 53(3):499-506 Doi: 10.1515/cclm-2014-0447
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Bjelic-Radisic, V; La Garde, M; Groselj-Strele, A; Eberhard, K; Samonigg, H; Loibner, H; Dandachi, N; Balic, M Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.
BMC Cancer. 2015; 15:1027-1027 Doi: 10.1186/s12885-015-2005-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Friesenbichler, J; Stojakovic, T; Leithner, A; Pichler, M The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
Am J Surg. 2015; 210(1): 111-116. Doi: 10.1016/j.amjsurg.2014.10.021
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Gary, T; Leithner, A; Pichler, M Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients.
Clin Chem Lab Med. 2015; 53(3):493-497 Doi: 10.1515/cclm-2014-0486
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396 Doi: 10.1038/tpj.2015.2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fallbericht

** Eisner, F; Pichler, M; Goletz, S; Stoeger, H; Samonigg, H A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options.
J Clin Pathol. 2015; 68(12):1044-1046 Doi: 10.1136/jclinpath-2015-202996 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Korrektur

** PETACC-8 study investigators; Thaler, J; Greil, R; Gaenzer, J; Eisterer, W; Tschmelitsch, J; Samonigg, H; Zabernigg, A; Schmid, F; Steger, G; Steinacher, R; Andel, J; Lang, A; Függer, R; Hofbauer, F; Woell, E; Geissler, D; Lenauer, A; Prager, M; Van Laethem, JL; Van Cutsem, E; D'Haens, G; Demolin, G; Kerger, J; Deboever, G; Ghillebert, G; Polus, M; Van Cutsem, E; RezaieKalantari, H; Delaunoit, T; Goeminne, JC; Peeters, M; Vergauwe, P; Houbiers, G; Humblet, Y; Janssens, J; Schrijvers, D; Vanderstraeten, E; Van Laethem, JL; Vermorken, J; Van Daele, D; Ferrante, M; Forget, F; Hendlisz, A; Yilmaz, M; Nielsen, SE; Vestermark, L; Larsen, J; Ychou, M; Zawadi, A; Zawadi, MA; Bouche, O; Mineur, L; Bennouna-Louridi, J; Dourthe, LM; Ychou, M; Boucher, E; Taieb, J; Pezet, D; Desseigne, F; Ducreux, M; Texereau, P; Miglianico, L; Rougier, P; Fratte, S; Levache, CB; Merrouche, Y; Ellis, S; Locher, C; Ramee, JF; Garnier, C; Viret, F; Chauffert, B; Cojean-Zelek, I; Michel, P; Lecaille, C; Borel, C; Seitz, JF; Smith, D; Lombard-Bohas, C; Andre, T; Gornet, JM; Fein, F; Coulon-Sfairi, MA; Kaminsky, MC; Lagasse, JP; Luet, D; Etienne, PL; Gasmi, M; Vanoli, A; Nguyen, S; Aparicio, T; Perrier, H; Stremsdoerfer, N; Laplaige, P; Arsene, D; Auby, D; Bedenne, L; Coriat, R; Denis, B; Geoffroy, P; Piot, G; Becouarn, Y; Bordes, G; Deplanque, G; Dupuis, O; Fruge, F; Guimbaud, R; Lecomte, T; Lledo, G; Sobhani, I; Asnacios, A; Azzedine, A; Desauw, C; Galais, MP; Gargot, D; Lam, YH; Abakar-Mahamat, A; Berdah, JF; Catteau, S; Clavero-Fabri, MC; Codoul, JF; Legoux, JL; Goldfain, D; Guichard, P; Verge, DP; Provencal, J; Vedrenne, B; Brezault-Bonnet, C; Cleau, D; Desir, JP; Fallik, D; Garcia, B; Gaspard, MH; Genet, D; Hartwig, J; Krummel, Y; MatysiakBudnik, T; Palascak-Juif, V; Randrianarivelo, H; Rinaldi, Y; Aleba, A; Darut-Jouve, A; de Gramont, A; Hamon, H; Wendehenne, F; Matzdorff, A; Stahl, MK; Schepp, W; Burk, M; Mueller, L; Folprecht, G; Geissler, M; Mantovani-Loeffler, L; Hoehler, T; Asperger, W; Kroening, H; von Weikersthal, LF; Fuxius, S; Groschek, M; Meiler, J; Trarbach, T; Rauh, J; Ziegenhagen, N; Kretzschmar, A; Graeven, U; Nusch, A; von Wichert, G; Hofheinz, RD; Kleber, G; Schmidt, KH; Vehling-Kaiser, U; Baum, C; Schuette, J; Haag, GM; Holtkamp, W; Potenberg, J; Reiber, T; Schliesser, G; Schmoll, HJ; Schneider-Kappus, W; Abenhardt, W; Denzlinger, C; Henning, J; Marxsen, B; GuenterDerigs, H; Lambertz, H; Becker-Boost, I; Caca, K; Constantin, C; Decker, T; Eschenburg, H; Gabius, S; Hebart, H; Hoffmeister, A; Horst, HA; Kremers, S; Leithaeuser, M; Mueller, S; Wagner, S; Daum, S; Schlegel, F; Stauch, M; Heinemann, V; Labianca, R; Colucci, G; Amadori, D; Mini, E; Falcone, A; Boni, C; Maiello, E; Latini, L; Zaniboni, A; Amadori, D; Aprile, G; Barni, S; Mattioli, R; Martoni, A; Passalacqua, R; Nicolini, M; Pasquini, E; Rabbi, C; Aitini, E; Ravaioli, A; Barone, C; Biasco, G; Tamberi, S; Gambi, A; Verusio, C; Marzola, M; Lelli, G; Boni, C; Cascinu, S; Bidoli, P; Vaghi, M; Cruciani, G; Di Costanzo, F; Sobrero, A; Mini, E; Petrioli, R; Aglietta, M; Alabiso, O; Capuzzo, F; Falcone, A; Corsi, DC; Labianca, R; Salvagni, S; Chiara, S; Ferraù, F; Giuliani, F; Lonardi, S; Gebbia, N; Mantovani, G; Sanches, E; Sanches, E; Mellidez, JC; Santos, P; Freire, J; Sarmento, C; Costa, L; Pinto, AM; Barroso, S; Santo, JE; Guedes, F; Monteiro, A; Sa, A; Furtado, I; Tabernero, J; Salazar, R; Aguilar, EA; Herrero, FR; Tabernero, J; Valera, JS; ValladaresAyerbes, M; FeliuBatlle, J; Gil, S; Gar ... Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol. 2015; 26(4):822-825 Doi: 10.1093/annonc/mdv070
PubMed FullText FullText_MUG

 

2014

Originalarbeit (Zeitschrift)

** Absenger, G; Benhaim, L; Szkandera, J; Zhang, W; Yang, D; Labonte, MJ; Pichler, M; Stotz, M; Samonigg, H; Renner, W; Gerger, A; Lenz, HJ The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.
Pharmacogenomics J. 2014; 14(2):130-134 Doi: 10.1038/tpj.2013.15
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Heitzer, E; Artl, M; Filipits, M; Resel, M; Graf, R; Weißenbacher, B; Lax, S; Gnant, M; Wrba, F; Greil, R; Dietze, O; Hofbauer, F; Böhm, G; Höfler, G; Samonigg, H; Schaberl-Moser, R; Balic, M; Dandachi, N Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.
Mod Pathol. 2014; 27(6):906-915 Doi: 10.1038/modpathol.2013.204 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203 Doi: 10.1136/jclinpath-2013-201904
Web of Science PubMed FullText FullText_MUG

 

** Popescu, RA; Schäfer, R; Califano, R; Eckert, R; Coleman, R; Douillard, JY; Cervantes, A; Casali, PG; Sessa, C; Van Cutsem, E; de Vries, E; Pavlidis, N; Fumasoli, K; Wörmann, B; Samonigg, H; Cascinu, S; Cruz Hernández, JJ; Howard, AJ; Ciardiello, F; Stahel, RA; Piccart, M The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).
Ann Oncol. 2014; 25(1):9-15 Doi: 10.1093/annonc/mdt522 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Regierer, AC; Wolters, R; Ufen, MP; Weigel, A; Novopashenny, I; Köhne, CH; Samonigg, H; Eucker, J; Possinger, K; Wischnewsky, MB An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.
Ann Oncol. 2014; 25(3):633-638 Doi: 10.1093/annonc/mdt539 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Pichler, M; Absenger, G; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.
Br J Cancer. 2014; 110(2):435-440 Doi: 10.1038/bjc.2013.785 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Szkandera, J; Seidel, J; Stojakovic, T; Samonigg, H; Reitz, D; Gary, T; Kornprat, P; Schaberl-Moser, R; Hoefler, G; Gerger, A; Pichler, M Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
PLoS One. 2014; 9(8):e104730-e104730 Doi: 10.1371/journal.pone.0104730 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Leithner, A; Pichler, M Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
PLoS One. 2014; 9(9):e107297-e107297 Doi: 10.1371/journal.pone.0107297 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Arminger, F; Weissmueller, M; Schaberl-Moser, R; Samonigg, H; Kornprat, P; Stojakovic, T; Avian, A; Gerger, A The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients.
Am J Surg. 2014; 208(2):210-214 Doi: 10.1016/j.amjsurg.2013.10.030
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Clin Cancer Res. 2014; 20(6):1687-1697 Doi: 10.1158/1078-0432.CCR-13-1517 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Eberhard, K; Leithner, A; Gerger, A The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
J Surg Oncol. 2014; 109(2):139-144 Doi: 10.1002/jso.23458
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Stotz, M; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Lackner, C; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.
Br J Cancer. 2014; 110(1):183-188 Doi: 10.1038/bjc.2013.701 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Fitzal, F; Filipits, MF; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Bartsch, R; Leitner, G; Gnant, M; Tailoring local therapy in post-menopausal endocrine responsive HER2neu negative breast cancer patients based on their genetic risk profile using Endopredict.
EUR J CANCER. 2014; 50: S97-S97.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
Web of Science

 

** Suppan, C; Bjelic-Radisic, V; La Garde, M; Samonigg, H; Dandachi, N; Balic, M N/L Ratio does not have predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
EUR J CANCER. 2014; 50: S193-S193.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

** Suppan, C; Milkovic, L; Gasparovic, AC; Samonigg, H; Dandachi, N; Balic, M Higher levels of HNE are associated with disease aggressiveness and worse outcome in breast cancer patients
EUR J CANCER. 2014; 50: S70-S70.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

2013

Originalarbeit (Zeitschrift)

** Absenger, G; Szkandera, J; Pichler, M; Stotz, M; Arminger, F; Weissmueller, M; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
Br J Cancer. 2013; 109(2):395-400 Doi: 10.1038/bjc.2013.346 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Absenger, G; Szkandera, J; Stotz, M; Pichler, M; Winder, T; Langsenlehner, T; Langsenlehner, U; Samonigg, H; Renner, W; Gerger, A A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
Mol Carcinog. 2013; 52 Suppl 1(9):E96-102 Doi: 10.1002/mc.22028
Web of Science PubMed FullText FullText_MUG

 

** Absenger, G; Szkandera, J; Stotz, M; Postlmayr, U; Pichler, M; Ress, AL; Schaberl-Moser, R; Loibner, H; Samonigg, H; Gerger, A Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
Anticancer Res. 2013; 33(10):4591-4594
Web of Science PubMed

 

** Aigelsreiter, A; Ress, AL; Bettermann, K; Schauer, S; Koller, K; Eisner, F; Kiesslich, T; Stojakovic, T; Samonigg, H; Kornprat, P; Lackner, C; Haybaeck, J; Pichler, M Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
Br J Cancer. 2013; 108(9):1830-1837 Doi: 10.1038/bjc.2013.165 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Andritsch, E; Stöger, H; Bauernhofer, T; Andritsch, H; Kasparek, AK; Schaberl-Moser, R; Ploner, F; Samonigg, H The ethics of space, design and color in an oncology ward.
Palliat Support Care. 2013; 11(3):215-221 Doi: 10.1017/S1478951512000077
Web of Science PubMed FullText FullText_MUG

 

** Eisner, F; Schaberl-Moser, R; Gerger, A; Samonigg, H; Pichler, M Successful use of sorafenib after bortezomib failure in metastatic follicular thyroid cancer - a case report.
Onkologie. 2013; 36(6):368-370 Doi: 10.1159/000351252 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Gnant, M; Pfeiler, G; Stöger, H; Mlineritsch, B; Fitzal, F; Balic, M; Kwasny, W; Seifert, M; Stierer, M; Dubsky, P; Greil, R; Steger, G; Samonigg, H; Fesl, C; Jakesz, R The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
Br J Cancer. 2013; 109(3):589-596 Doi: 10.1038/bjc.2013.367 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Heitzer, E; Auer, M; Gasch, C; Pichler, M; Ulz, P; Hoffmann, EM; Lax, S; Waldispuehl-Geigl, J; Mauermann, O; Lackner, C; Höfler, G; Eisner, F; Sill, H; Samonigg, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.
Cancer Res. 2013; 73(10):2965-2975 Doi: 10.1158/0008-5472.CAN-12-4140 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Heitzer, E; Auer, M; Hoffmann, EM; Pichler, M; Gasch, C; Ulz, P; Lax, S; Waldispuehl-Geigl, J; Mauermann, O; Mohan, S; Pristauz, G; Lackner, C; Höfler, G; Eisner, F; Petru, E; Sill, H; Samonigg, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.
Int J Cancer. 2013; 133(2):346-356 Doi: 10.1002/ijc.28030 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Heitzer, E; Ulz, P; Belic, J; Gutschi, S; Quehenberger, F; Fischereder, K; Benezeder, T; Auer, M; Pischler, C; Mannweiler, S; Pichler, M; Eisner, F; Haeusler, M; Riethdorf, S; Pantel, K; Samonigg, H; Hoefler, G; Augustin, H; Geigl, JB; Speicher, MR Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.
Genome Med. 2013; 5(4):30-30 Doi: 10.1186/gm434 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hofmann, G; Balic, M; Dandachi, N; Resel, M; Schippinger, W; Regitnig, P; Samonigg, H; Bauernhofer, T The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Clin Biochem. 2013; 46(15):1585-1589 Doi: 10.1016/j.clinbiochem.2013.06.010
Web of Science PubMed FullText FullText_MUG

 

** Pfeiler, G; Stöger, H; Dubsky, P; Mlineritsch, B; Singer, C; Balic, M; Fitzal, F; Moik, M; Kwasny, W; Selim, U; Renner, K; Ploner, F; Steger, GG; Seifert, M; Hofbauer, F; Sandbichler, P; Samonigg, H; Jakesz, R; Greil, R; Fesl, C; Gnant, M; ABCSG Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Br J Cancer. 2013; 108(7):1408-1414 Doi: 10.1038/bjc.2013.114 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Eisner, F; Szkandera, J; Absenger, G; Kornprat, P; Lackner, C; Samonigg, H; Gerger, A; Pichler, M Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
J Clin Pathol. 2013; 66(9):753-757 Doi: 10.1136/jclinpath-2012-201394
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Gerger, A; Eisner, F; Szkandera, J; Loibner, H; Ress, AL; Kornprat, P; AlZoughbi, W; Zoughbi, WA; Seggewies, FS; Lackner, C; Stojakovic, T; Samonigg, H; Hoefler, G; Pichler, M Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.
Br J Cancer. 2013; 109(2):416-421 Doi: 10.1038/bjc.2013.332 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Samonigg, H; Glehr, M; Zacherl, M; Stojakovic, T; Gerger, A; Leithner, A Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Br J Cancer. 2013; 108(8):1677-1683 Doi: 10.1038/bjc.2013.135 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Pichler, M; Stotz, M; Langsenlehner, T; Samonigg, H; Renner, W; Gerger, A Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.
J Cancer Res Clin Oncol. 2013; 139(9):1457-1464 Doi: 10.1007/s00432-013-1461-x
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Samonigg, H; Maurer-Ertl, W; Stojakovic, T; Ploner, F; Leithner, A; Pichler, M Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
Br J Cancer. 2013; 109(9):2316-2322 Doi: 10.1038/bjc.2013.595 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Stotz, M; Eisner, F; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
PLoS One. 2013; 8(11):e78225-e78225 Doi: 10.1371/journal.pone.0078225 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Winder, T; Stotz, M; Weissmueller, M; Langsenlehner, T; Pichler, M; Samonigg, H; Renner, W; Gerger, A; Absenger, G A common gene variant in PLS3 predicts colon cancer recurrence in women.
Tumour Biol. 2013; 34(4):2183-2188 Doi: 10.1007/s13277-013-0754-7
Web of Science PubMed FullText FullText_MUG

 

Korrektur

** Stotz, M; Gerger, A; Eisner, F; Szkandera, J; Loibner, H; Ress, AL; Kornprat, P; Alzoughbi, W; Seggewies, FS; Lackner, C; Stojakovic, T; Samonigg, H; Hoefler, G; Pichler, M Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer.
Br J Cancer. 2013; 109(7): 2026-2026. Doi: 10.1038/bjc.2013.591 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Andritsch, E; Farkas, C; Zloklikovits, S; Samonigg, H Hope and Meaning in the Context of Different Psychological Intervention Settings: When to Whom - How?.
PSYCHO-ONCOL. 2013; 22: 175-175.-15th World Congress of Psychooncology Innovation in Psychooncology, clinical care- research- advocacy ; NOV 4-8, 2013; Rotterdam, Netherlands. [Poster]
Web of Science

 

** Andritsch, E; Farkas, C; Zloklikovits,S; Samonigg, H;Bauernhofer,T Hope and Optimism - The Additional Benefit for Patients With Cancer in the Interdisciplinary Treatment - From the Perspective of Psychoneuroimmunology.
PSYCHO-ONCOL. 2013; 22: 175-176.-15th World Congress of Psychooncology, Innovation in Psychooncology, clinical care- research-advocacy; NOV 4-8, 2013; Rotterdam, Netherlands. [Poster]
Web of Science

 

** Farkas, C; Ladinek, V; Zloklikovits, S; Samonigg, H; Andritsch, E Effects of psycho-social variables on compliance and adherence in patients with cancer: A literature overview and preliminary data of a study relating antiemetic therapy during chemotherapy in a sample of patients treated at the Division of Oncology, Graz
ONKOLOGIE. 2013; 36: 109-109. [Oral Communication]
Web of Science

 

** Walter, E; Said, M; Bauer, M; Gastl, G; Samonigg, H COST OF CANCER IN THE AUSTRIAN HOSPITAL SETTING
VALUE HEALTH. 2013; 16(7): A407-A407. Doi: 10.1016/j.jval.2013.08.485 [Poster]
Web of Science FullText FullText_MUG

 

2012

Originalarbeit (Zeitschrift)

** Aigelsreiter, A; Haybaeck, J; Schauer, S; Kiesslich, T; Bettermann, K; Griessbacher, A; Stojakovic, T; Bauernhofer, T; Samonigg, H; Kornprat, P; Lackner, C; Pichler, M NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.
Hum Pathol. 2012; 43(7):1012-1019 Doi: 10.1016/j.humpath.2011.08.009
Web of Science PubMed FullText FullText_MUG

 

** Dubsky, PC; Jakesz, R; Mlineritsch, B; Pöstlberger, S; Samonigg, H; Kwasny, W; Tausch, C; Stöger, H; Haider, K; Fitzal, F; Singer, CF; Stierer, M; Sevelda, P; Luschin-Ebengreuth, G; Taucher, S; Rudas, M; Bartsch, R; Steger, GG; Greil, R; Filipcic, L; Gnant, M Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2012; 30(7):722-728 Doi: 10.1200/JCO.2011.36.8993 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gary, T; Belaj, K; Steidl, K; Pichler, M; Eisner, F; Stöger, H; Hafner, F; Froehlich, H; Samonigg, H; Pilger, E; Brodmann, M Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival.
Br J Cancer. 2012; 107(8):1244-1248 Doi: 10.1038/bjc.2012.401 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Heitzer, E; Sandner-Kiesling, A; Schippinger, W; Stohscheer, I; Osprian, I; Bitsche, S; Eisner, F; Verebes, J; Hofmann, G; Samonigg, H IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer.
Pain Physician. 2012; 15(6):499-510 Doi: 10.36076/ppj.2012/15/499 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Winter, E; Stotz, M; Eberhard, K; Samonigg, H; Lax, S; Hoefler, G; Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.
Br J Cancer. 2012; 106(11):1826-1832 Doi: 10.1038/bjc.2012.175 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rainer, PP; Doleschal, B; Kirk, JA; Sivakumaran, V; Saad, Z; Groschner, K; Maechler, H; Hoefler, G; Bauernhofer, T; Samonigg, H; Hutterer, G; Kass, DA; Pieske, B; von, Lewinski, D; Pichler, M Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes.
BJU Int. 2012; 110(10):1455-62 Doi: 10.1111/j.1464-410X.2012.11134.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Mol Genet Genomics. 2012; 287(9):755-764 Doi: 10.1007/s00438-012-0715-7
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Stotz, M; Weissmueller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A The Functional Polymorphism of Erythropoietin Gene rs1617640 G>T Is Not Associated with Susceptibility and Clinical Outcome of Early-stage Breast Cancer.
Anticancer Res. 2012; 32(8):3473-3478
Web of Science PubMed

 

Abstract (Zeitschrift)

** Absenger, G; Szkandera, J; Weissmuller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, HS; Gerger, A; The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer.
ONKOLOGIE. ONKOLOGIE35: 55-56. BASEL: KARGER; [Poster]
Web of Science

 

** Gary, T; Belaj, K; Steidl, K; Pichler, M; Eisner, F; Hafner, F; Froehlich, H; Samonigg, H; Pilger, E; Brodmann, M Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
THROMB RES. 2012; 129: S181-S181.-6th International Conference on Thrombosis and Hemostasis Issues in Cancer; APR 20-22, 2012; Bergamo, ITALY. Doi: 10.1016/S0049-3848(12)70103-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Absenger, G; Szkandera, J; Samonigg, H; Krippl, P; Renner, W; COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS.
ANN ONCOL. 2012; 23: 86-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Thurner, E-M; Absenger, G; Szkandera, J; Samonigg, H; Glehr, M; Krippl, P; Renner, W Genetic variants of UGT1A4 and their impact on relapse-free survival in Tamoxifen treated breast cancer patients.
Onkologie. 2012; 35(S 6):64-64.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY. [Poster]
Web of Science

 

** Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Winder, T; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575. [Poster]
Web of Science

 

** Szkandera, J; Absenger, G; Stotz, M; Weissmuller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A The functional polymorphism of erythropoietin gene rs1617640 G > T is not associated with susceptibility and clinical outcome of early-stage breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575. [Poster]
Web of Science

 

** Szkandera, J; Winder, T; Absenger, G; Stotz, M; Weissmuller, M; Langsenlehner, T; Hofmann, G; Samonigg, H; Renner, W; Gerger, A; A COMMON GENE VARIANT IN PLS3 PREDICTS COLON CANCER RECURRENCE IN WOMEN.
ANN ONCOL. 2012; 23: 83-83.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

2011

Originalarbeit (Zeitschrift)

** Balic, M; Rapp, N; Stanzer, S; Lin, H; Strutz, J; Szkandera, J; Daidone, MG; Samonigg, H; Cote, RJ; Dandachi, N Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells.
Appl Immunohistochem Mol Morphol. 2011; 19(1):33-40 Doi: 10.1097/PAI.0b013e3181ebf4e8
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Bauernhofer, T; Pichler, M; Wieckowski, E; Stanson, J; Aigelsreiter, A; Griesbacher, A; Groselj-Strele, A; Linecker, A; Samonigg, H; Langner, C; Whiteside, TL Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.
Br J Cancer. 2011; 104(10):1641-1648 Doi: 10.1038/bjc.2011.131 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hofmann, G; Langsenlehner, U; Langsenlehner, T; Glehr, M; Gerger, A; Absenger, G; Szkandera, J; Fuerst, F; Samonigg, H; Krippl, P; Renner, W Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients.
Anticancer Res. 2011; 31(4):1373-1377
Web of Science PubMed

 

** Pfeiler, G; Königsberg, R; Fesl, C; Mlineritsch, B; Stoeger, H; Singer, CF; Pöstlberger, S; Steger, GG; Seifert, M; Dubsky, P; Taucher, S; Samonigg, H; Bjelic-Radisic, V; Greil, R; Marth, C; Gnant, M Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
J Clin Oncol. 2011; 29(19):2653-2659 Doi: 10.1200/JCO.2010.33.2585 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Hofmann, G; Geigl, JB; Kastner, N; Leithner, A; Koppany, B; Samonigg, H; Gruber, G Genetic differences in preoperative specimen of osteosarcoma and their impact on response to neoadjuvant chemotherapy
ONKOLOGIE. 2011; 34: 251-252.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SCHWEIZ. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Bitsche, S; Absenger, G; Samonigg, H; Krippl, P; Renner, W RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS IS NOT ASSOCIATED WITH SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRIN RECEPTOR SUBUNITS
ANN ONCOL. 2011; 22: v109-v109.-ESMO 13th World Congress on Gastrointestinal Cancer ; JUN 22-25, 2011; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W A COMMON HEREDITARY SINGLE NUCLEOTIDE POLYMORPHISM IN THE IN THE GENE OF DEATH RECEPTOR 4 (TNFRSF10A) AND ITS IMPACT ON OVERALL SURVIVAL IN RECTAL CANCER PATIENTS
ANN ONCOL. . 2011; 22: v129-v129.-ESMO 13th World Congress on Gastrointestinal Cancer; JUN 22-25, 2011; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W Common single nucleotide polymorphisms in the genes of integrin alpha-2 and beta-3 subunits are not associated with overall survival in rectal cancer patients
ONKOLOGIE. 2011; 34: 245-246.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SWITZERLAND. [Poster]
Web of Science

 

2010

Originalarbeit (Zeitschrift)

** Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Knechtel, G; Szkandera, J; Samonigg, H; Krippl, P; Langsenlehner, U Association of interleukin-10 gene variation with breast cancer prognosis.
Breast Cancer Res Treat. 2010; 119(3):701-705 Doi: 10.1007/s10549-009-0417-y
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Knechtel, G; Hofmann, G; Gerger, A; Renner, W; Langsenlehner, T; Szkandera, J; Wolf, G; Samonigg, H; Krippl, P; Langsenlehner, U Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.
J Cancer Res Clin Oncol. 2010; 136(12):1813-1819 Doi: 10.1007/s00432-010-0839-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Knechtel, G; Stoeger, H; Szkandera, J; Dorr, K; Beham, A; Samonigg, H Desmoid tumor treated with polychemotherapy followed by imatinib: a case report and review of the literature.
Case Rep Oncol. 2010; 3(2): 287-293. Doi: 10.1159/000318873 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Langner, C; Dehchamani, D; Gerger, A Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
Mol Carcinog. 2010; 49(9):805-809 Doi: 10.1002/mc.20655
Web of Science PubMed FullText FullText_MUG

 

** Stanzer, S; Balic, M; Strutz, J; Heitzer, E; Obermair, F; Hauser-Kronberger, C; Samonigg, H; Dandachi, N Rapid and reliable detection of LINE-1 hypomethylation using high-resolution melting analysis.
Clin Biochem. 2010; 43(18):1443-1448 Doi: 10.1016/j.clinbiochem.2010.09.013
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stanzer, S; Janesch, B; Resel, M; Augustin, T; Samonigg, H; Bauernhofer, T The role of activation-induced cell death in the higher onset of spontaneous apoptosis of NK cell subsets in patients with metastatic epithelial cancer.
Cell Immunol. 2010; 261(2):99-104 Doi: 10.1016/j.cellimm.2009.11.006
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.
Anticancer Res. 2010; 30(6):2393-2397
Web of Science PubMed Google Scholar

 

** Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Gallè, G; Samonigg, H; Hofmann, G Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodies.
Onkologie. 2010; 33(8-9):452-454 Doi: 10.1159/000317269 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Samonigg, H; Krippl, P; Renner, W COMMON VEGF RECEPTOR GENE POLYMORPHISMS AND THEIR INFLUENCE ON OVERALL SURVIVAL IN COLORECTAL CANCER PATIENTS
Annals of Oncology2010; 21(S 6):35-35.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Samonigg, H; Krippl, P; Renner, W ASSOCIATION OF COMMON SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRINS WITH METASTASIS-FREE SURVIVAL IN RECTAL CANCER PATIENTS
Annals of Oncology2010; 21(S 6):59-59.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

** Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Dehchamani, D; Gerger, A Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):225-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 ) [Oral Communication]
Web of Science

 

** Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A Association of Hypoxia Inducible Factor 1-alpha Gene Polymorphisms and Colorectal Cancer Prognosis.
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):226-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 ) [Oral Communication]
Web of Science

 

2009

Originalarbeit (Zeitschrift)

** Balic, M; Pichler, M; Strutz, J; Heitzer, E; Ausch, C; Samonigg, H; Cote, RJ; Dandachi, N High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis.
J Mol Diagn. 2009; 11(2):102-108 Doi: 10.2353/jmoldx.2009.080109 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Calabrò, A; Beissbarth, T; Kuner, R; Stojanov, M; Benner, A; Asslaber, M; Ploner, F; Zatloukal, K; Samonigg, H; Poustka, A; Sültmann, H Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
Breast Cancer Res Treat. 2009; 116(1):69-77 Doi: 10.1007/s10549-008-0105-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Hofmann, G; Langsenlehner, U; Renner, W; Weitzer, W; Wehrschütz, M; Wascher, T; Samonigg, H; Krippl, P Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk.
Int J Colorectal Dis. 2009; 24(2):159-163 Doi: 10.1007/s00384-008-0587-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Hofmann-Wellenhof, R; Samonigg, H; Smolle, J In vivo confocal laser scanning microscopy in the diagnosis of melanocytic skin tumours.
Br J Dermatol. 2009; 160(3):475-481 Doi: 10.1111/j.1365-2133.2008.08995.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Pöstlberger, S; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Bjelic-Radisic, V; Samonigg, H; Tausch, C; Eidtmann, H; Steger, G; Kwasny, W; Dubsky, P; Fridrik, M; Fitzal, F; Stierer, M; Rücklinger, E; Greil, R; ABCSG-12 Trial Investigators; Marth, C Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med. 2009; 360(7):679-691 Doi: 10.1056/NEJMoa0806285 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hofmann, G; Langsenlehner, U; Langsenlehner, T; Yazdani-Biuki, B; Clar, H; Gerger, A; Fuerst, F; Samonigg, H; Krippl, P; Renner, W A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival.
J Cell Mol Med. 2009; 13(9B):3699-3702 Doi: 10.1111/j.1582-4934.2009.00720.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Wohlkoenig, C; Bálint, Z; Polachova, J; Olschewski, A; Samonigg, H; Popper, HH; Olschewski, H Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
Lung Cancer. 2009; 65(1):98-104 Doi: 10.1016/j.lungcan.2008.10.015
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Pichler, M; Balic, M; Stadelmeyer, E; Ausch, C; Wild, M; Guelly, C; Bauernhofer, T; Samonigg, H; Hoefler, G; Dandachi, N Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.
J Mol Diagn. 2009; 11(2):140-147 Doi: 10.2353/jmoldx.2009.080100 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Gnant, M; Dubsky, P; Fitzal, F; Blaha, P; Schoppmann, S; Steger, G; Marth, C; Samonigg, H; Hüttner, K; Fohler, H; Ruecklinger, E; Jakesz, R; Greil, R; Austrian Breast and Colorectal Cancer Study Group Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Clin Breast Cancer. 2009; 9 Suppl 1: S18-S27. Doi: 10.3816/CBC.2009.s.002
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Chan, A; Vanlemmens, L; Conte, PF; Beith, J; Samonigg, H; Verma, S; Srimuninnimit, V; Martoni, A; Miles, DW Efficacy of bevacizumab (BV) plus docetaxel (D) does not correlate with hypertension (HTN) or G-CSF use in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) in the AVAIDO phase III study
CANCER RES. 2009; 69(2):114S-114S.-31st Annual San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, TX. [Poster]
Web of Science

 

** Goetz, M; Ames, M; Gnant, M; Filpits, M; Jakesz, R; Greil, R; Marth, C; Samonigg, H; Suman, V; Safgren, S; Kuffel, M; Weinshilboum, R; Erlander, M; Ma, XJ; Ingle, J Pharmacogenetic (CYP2D6) and gene expression profiles (HOXB13/IL17BR and molecular grade index) for prediction of adjuvant endocrine therapy benefit in the ABCSG 8 trial.
CANCER RES. 2009; 69(2):77S-77S.-31st Annual San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, TX. [Keynote lecture]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W A hereditary single nucleotide polymorphism in the FAS gene and its impact on developing metastases in rectal cancer patients.
Annals of Oncology. 2009; 20(S 7):58-58.-11th World Congress on Gastrointestinal Cancer ; JUNE 24-27; Barcelona, SPAIN. [Poster]
Web of Science

 

** Jakesz, R; Gnant, M; Griel, R; Tausch, C; Samonigg, H; Kwasny, W; Kubista, E; Stierer, M; Luschin, G; Ruecklinger, E; Mittlbock, M Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8
CANCER RES. 2009; 69(2):67S-67S.-31st Annual San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, TX. [Keynote lecture]
Web of Science

 

** Loibner, H; Janzek, E; Peball, B; Schaefer, R; Schustet, M; Bauernhofer, T; Samonigg, H Elevated Angiotensin II Levels in Plasma and Malignant Effusions of Cancer Patients: Recombinant Human ACE2 as Novel Biological Cancer Therapy
J IMMUNOTHER. 2009; 32(9):952-952. [Poster]
Web of Science

 

** Steger, GG; Greil, R; Jakesz, R; Lang, A; Mlineritsch, B; Melbinger-Zeinitzer, E; Marth, C; Samonigg, H; Kubista, E; Gnant, M Final Results of ABCSG-24, a Randomized Phase III Study Comparing Epirubicin, Docetaxel, and Capecitabine (EDC) to Epirubicin and Docetaxel (ED) as Neoadjuvant Treatment for Early Breast Cancer and Comparing ED/EDC plus Trastuzumab (T) to ED/EDC as Neoadjuvant Treatment for Early HER-2 Positive Breast Cancer
CANCER RES. 2009; 69(24):564S-564S. [Poster]
Web of Science

 

** Steger, GG; Greil, R; Jakesz, R; Lang, A; Mlineritsch, B; Melbinger-Zeinitzer, E; Martin, C; Samonigg, H; Kubista, E; Gnant, M A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer - first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)
EJC SUPPL. 2009; 7(3):3-3. Doi: 10.1016/S1359-6349(09)72030-0 [Oral Communication]
Web of Science FullText FullText_MUG

 

2008

Originalarbeit (Zeitschrift)

** Dubsky, P; Sevelda, P; Jakesz, R; Hausmaninger, H; Samonigg, H; Seifert, M; Denison, U; Mlineritsch, B; Steger, G; Kwasny, W; Stöger, H; Bartsch, R; Stierer, M; Taucher, S; Fridrik, M; Schippinger, W; Greil, R; Pötter, R; Gnant, M; Austrian Breast and Colorectal Cancer Study Group Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Clin Cancer Res. 2008; 14(7):2082-2087 Doi: 10.1158/1078-0432.CCR-07-2068 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Hofmann-Wellenhof, R; Langsenlehner, U; Richtig, E; Koller, S; Weger, W; Ahlgrimm-Siess, V; Horn, M; Samonigg, H; Smolle, J In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour images.
Br J Dermatol. 2008; 158(2):329-333 Doi: 10.1111/j.1365-2133.2007.08389.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Wiltgen, M; Langsenlehner, U; Richtig, E; Horn, M; Weger, W; Ahlgrimm-Siess, V; Hofmann-Wellenhof, R; Samonigg, H; Smolle, J Diagnostic image analysis of malignant melanoma in in vivo confocal laser-scanning microscopy: a preliminary study
SKIN RES TECHNOL. 2008; 14(3): 359-363. Doi: 10.1111/j.1600-0846.2008.00303.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gnant, M; Mlineritsch, B; Luschin-Ebengreuth, G; Kainberger, F; Kässmann, H; Piswanger-Sölkner, JC; Seifert, M; Ploner, F; Menzel, C; Dubsky, P; Fitzal, F; Bjelic-Radisic, V; Steger, G; Greil, R; Marth, C; Kubista, E; Samonigg, H; Wohlmuth, P; Mittlböck, M; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group (ABCSG) Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Lancet Oncol. 2008; 9(9):840-849 Doi: 10.1016/S1470-2045(08)70204-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hofmann, G; Langsenlehner, U; Renner, W; Langsenlehner, T; Yazdani-Biuki, B; Clar, H; Gerger, A; Wehrschuetz, M; Samonigg, H; Krippl, P Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.
J Cancer Res Clin Oncol. 2008; 134(5):591-595 Doi: 10.1007/s00432-007-0322-x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Horn, M; Gerger, A; Ahlgrimm-Siess, V; Weger, W; Koller, S; Kerl, H; Samonigg, H; Smolle, J; Hofmann-Wellenhof, R Discrimination of actinic keratoses from normal skin with reflectance mode confocal microscopy.
Dermatol Surg. 2008; 34(5):620-625 Doi: 10.1111/j.1524-4725.2008.34195.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langsenlehner, U; Wolf, G; Langsenlehner, T; Gerger, A; Hofmann, G; Clar, H; Wascher, TC; Paulweber, B; Samonigg, H; Krippl, P; Renner, W Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
Breast Cancer Res Treat. 2008; 109(2):297-304 Doi: 10.1007/s10549-007-9655-z
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ludwig, H; Auberger, T; Burghuber, OCh; Gnant, M; Hopfinger, G; Jäger, U; Keil, F; Kornek, G; Linkesch, W; Petru, E; Pirker, R; Pittermann, E; Reinthaller, A; Samonigg, H; Steger, G; Stockenhuber, F; Studnicka, M; Weiss, G; Zielinski, C The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases
Wien Klin Wochenschr. 2008; 120(15-16): 507-513. Doi: 10.1007/s00508-008-1007-4
Web of Science PubMed FullText FullText_MUG

 

** Stanzer, S; Dandachi, N; Balic, M; Resel, M; Samonigg, H; Bauernhofer, T Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.
J Clin Immunol. 2008; 28(2):107-114 Doi: 10.1007/s10875-007-9139-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stefatic, D; Riederer, M; Balic, M; Dandachi, N; Stanzer, S; Janesch, B; Resel, M; Ler, D; Samonigg, H; Bauernhofer, T Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum.
Bosn J Basic Med Sci. 2008; 8(3):245-250 Doi: 10.17305/bjbms.2008.2926 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Taucher, S; Steger, GG; Jakesz, R; Tausch, C; Wette, V; Schippinger, W; Kwasny, W; Reiner, G; Greil, R; Dubsky, P; Poestlberger, S; Tschmelitsch, J; Samonigg, H; Gnant, M; Austrian Breast and Colorectal Cancer Study Group-07 The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
Breast Cancer Res Treat. 2008; 112(2): 309-316. Doi: 10.1007/s10549-007-9844-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Gerger, A; Langsenlehner, U; Hofmann, G; Samonigg, H; Krippl, P A multigenic approach to predict breast cancer risk
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A45-A45.-45.-Jahrestagung der österreichischen Gesellschaft für Innere Medizin; Sep 17-20, 2008; Graz, AUSTRIA.. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W Hereditary gene polymorphisms of vascular endothelial growth factor and colorectal cancer.
ANN ONCOL. 2008; 19(S6):68-68.-10th World Congress on Gastrointestinal Cancer; JUNE 25-28, 2008; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W Association of a common-670 A > G polymorphism in the gene of TNFRSF6 (FAS) with overall survival in colorectal cancer patients
ANN ONCOL. 2008; 19(S 6):68-68. [Oral Communication]
Web of Science

 

** Spat, S; Habacher, W; Rakovac, I; Baumgartner, J; Schippinger, W; Samonigg, H; Pieber, TR SHIFT OF PUBLIC HEALTH CARE EXPENDITURES FOR PALLIATIVE CANCER PATIENTS FROM INPATIENT TO OUTPATIENT EFFECTED BY HOME CARE SUPPORT TEAMS PROVIDED BY A UNIVERSITY HOSPITAL IN AUSTRIA
VALUE HEALTH. 2008; 11(6):A479-A480. Doi: 10.1016/S1098-3015(10)66600-4 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Stanzer, S; Dandachi, N; Balic, M; Bauernhofer, T; Samonigg, H The role of NKG2D expression and soluble MICA and MICB in the higher onset of apoptosis of NK cell subsets in patients with epithelial cancer
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A46-A46. [Poster]
Web of Science

 

2007

Originalarbeit (Zeitschrift)

** Andritsch, E; Dietmaier, G; Hofmann, G; Zloklikovits, S; Samonigg, H Global quality of life and its potential predictors in breast cancer patients: an exploratory study.
Support Care Cancer. 2007; 15(1):21-30 Doi: 10.1007/s00520-006-0089-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Asslaber, M; Abuja, PM; Stark, K; Eder, J; Gottweis, H; Trauner, M; Samonigg, H; Mischinger, HJ; Schippinger, W; Berghold, A; Denk, H; Zatloukal, K The Genome Austria Tissue Bank (GATiB).
Pathobiology. 2007; 74(4):251-258 Doi: 10.1159/000104453 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gerger, A; Langsenlehner, U; Renner, W; Weitzer, W; Eder, T; Yazdani-Biuki, B; Hofmann, G; Samonigg, H; Krippl, P A multigenic approach to predict breast cancer risk.
Breast Cancer Res Treat. 2007; 104(2):159-164 Doi: 10.1007/s10549-006-9408-4
Web of Science PubMed FullText FullText_MUG

 

** Gerger, A; Smolle-Jüttner, FM; Samonigg, H; Wehrschütz, M; Smolle, J Asymptomatic primary malignant melanoma of the esophagus.
Onkologie. 2007; 30(4):206-208 Doi: 10.1159/000099987 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Horn, M; Gerger, A; Koller, S; Weger, W; Langsenlehner, U; Krippl, P; Kerl, H; Samonigg, H; Smolle, J The use of confocal laser-scanning microscopy in microsurgery for invasive squamous cell carcinoma.
Br J Dermatol. 2007; 156(1): 81-84. Doi: 10.1111/j.1365-2133.2006.07574.x
Web of Science PubMed FullText FullText_MUG

 

** Jakesz, R; Greil, R; Gnant, M; Schmid, M; Kwasny, W; Kubista, E; Mineritsch, B; Tausch, C; Stierer, M; Hofbauer, F; Renner, K; Dadak, C; Ruecklinger, E; Samonigg, H Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
J Natl Cancer Inst. 2007; 99(24):1845-1853 Doi: 10.1093/jnci/djm246 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schippinger, W; Dandachi, N; Regitnig, P; Hofmann, G; Balic, M; Neumann, R; Samonigg, H; Bauernhofer, T The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer.
Am J Clin Pathol. 2007; 128(4):630-637 Doi: 10.1309/51KPD70348RP6XTE [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schippinger, W; Samonigg, H; Schaberl-Moser, R; Greil, R; Thödtmann, R; Tschmelitsch, J; Jagoditsch, M; Steger, GG; Jakesz, R; Herbst, F; Hofbauer, F; Rabl, H; Wohlmuth, P; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
BRIT J CANCER. 2007; 97(8): 1021-1027. Doi: 10.1038/sj.bjc.6604011 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Steger, GG; Galid, A; Gnant, M; Mlineritsch, B; Lang, A; Tausch, C; Rudas, M; Greil, R; Wenzel, C; Singer, CF; Haid, A; Postlberger, S; Samonigg, H; Luschin-Ebengreuth, G; Kwasny, W; Klug, E; Kubista, E; Menzel, C; Jakesz, R Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
J Clin Oncol. 2007; 25(15):2012-2018 Doi: 10.1200/JCO.2006.09.1777 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Gerger, A; Hofmann-Wellenhof, R; Langsenlehner, U; Koller, S; Weger, W; Richtig, E; Horn, M; Samonigg, H; Smolle, J In vivo confocal laser-scanning microscopy: bringing melanoma histopathology to the bedside.
J Invest Dermatol; 2007; 127(S2):S49-S49.-37 th Annual ESDR Meeting; SEP 5-8, 2007; Zürich, Switzerland. [Poster]
Web of Science

 

** Gnant, M; Mlineritsch, B; Luschin-Ebengreuth, G; Kainberger, F; Kaessmann, H; Piswanger-Soelkner, C; Seifert, M; Schippinger, W; Menzel, C; Dubsky, P; Fitzal, F; Steger, G; Greil, R; Marth, C; Kubista, E; Samonigg, H; Jakesz, R Bone mineral density (BMD) at 5 years after diagnosis in premenopausal patients with endocrine-responsive breast cancer, after 3 years of adjuvant endocrine treatment with goserelin and tamoxifen or anastrozole or both treatments in combination with zoledronic acid - new results from ABCSG-12
BREAST CANCER RES TREAT. 2007; 106: S8-S8. [Oral Communication]
Web of Science

 

** Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Fuerst, F; Renner, W; Samonigg, H; Krippl, P; Langsenlehner, U The ITGA2 807C > T polymorphism is associated with reduced colorectal cancer susceptibility
ANN ONCOL. 2007; 18: VII38-VII38.-2007 World Congress on Gastrointestinal Cancer; JUN 27-30, 2007; Barcelona, SPAIN. [Poster]
Web of Science

 

** Horn, M; Gerger, A; Ahlgrimm-Siess, V; Weger, W; Koller, S; Kerl, H; Samonigg, H; Smolle, J; Hofmann-Wellenhof, R Diagnostic in vivo confocal laser-scanning microscopy of actinic keratoses
J INVEST DERMATOL. ; 127: S41-S41.-68th Annual Meeting of the Society for Investigative Dermatology; May 9-12, 2007; Los Angeles, USA. [Poster]
Web of Science

 

** Horn, M; Gerger, A; Wiltgen, M; Langsenlehner, U; Hofmann-Wellenhof, R; Weger, W; Richtig, E; Samonigg, H; Smolle, J Diagnostic image analysis of malignant melanoma in in-vivo confocal laser-scanning microscopy.
J Invest Dermatol;2007; 127(S2):S91-S91.-37 th Annual ESDR Meeting; SEP 5-8, 2007; Zürich, Switzerland. [Poster]
Web of Science

 

** Schippinger, W; Lileg, B; Ploner, F; Weitzer, W; Bauemhofer, T; Samonigg, H Neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin, docetaxel and trastuzumab in HER-2/neu overexpressing breast cancer
ANN ONCOL. 2007; 18: 166-166. [Poster]
Web of Science

 

** Zloklikovits, S; Ladinek, V; Andritsch, E; Samonigg, H Comparisons of patient and caregiver symptom ratings in palliative care: the role of their subjective distress.
PSYCHO-ONCOL. 2007; 16(9):S30-S31.-IPOS 9th World Congress of Psycho-Oncology; SEP 16-21, 2007; London, United Kingdom. [Oral Communication]
Web of Science

 

2006

Originalarbeit (Zeitschrift)

** Gerger, A; Koller, S; Weger, W; Richtig, E; Kerl, H; Samonigg, H; Krippl, P; Smolle, J Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors.
Cancer. 2006; 107(1): 193-200. Doi: 10.1002/cncr.21910 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Pressetext

 

** Hofmann, G; Bauernhofer, T; Krippl, P; Lang-Loidolt, D; Horn, S; Goessler, W; Schippinger, W; Ploner, F; Stoeger, H; Samonigg, H Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.
BMC Cancer. 2006; 6(2):1-1 Doi: 10.1186/1471-2407-6-1 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Eder, T; Wascher, TC; Paulweber, B; Clar, H; Hofmann, G; Samonigg, H; Krippl, P Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
Breast Cancer Res Treat. 2006; 97(1):67-72 Doi: 10.1007/s10549-005-9089-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langsenlehner, U; Yazdani-Biuki, B; Eder, T; Renner, W; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H; Krippl, P The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
Clin Cancer Res. 2006; 12(4):1392-1394 Doi: 10.1158/1078-0432.CCR-05-2055 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T; Samonigg, H Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
Oncology. 2006; 70(4):290-293 Doi: 10.1159/000094890
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schippinger, W; Regitnig, P; Dandachi, N; Wernecke, KD; Bauernhofer, T; Samonigg, H; Moinfar, F Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer.
Virchows Arch. 2006; 449(1):24-30 Doi: 10.1007/s00428-006-0213-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Strohscheer, I; Verebes, J; Samonigg, H Implementation of a palliative care team in an Austrian university hospital.
Support Care Cancer. 2006; 14(8):795-801 Doi: 10.1007/s00520-006-0017-x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Andritsch, E; Dietmaier, G; Bauernhofer, T; Samonigg, H The influence of an artistic ward design on the wellbeing of cancer patients at the Division of Oncology at the Medical University of Graz
PSYCHO-ONCOL. 2006; 15(2):S71-S71.-8th World Congress of Psycho-Oncology; OCT 16-21, 2006; Ferrara-Venice, Italy. [Poster]
Web of Science

 

** Andritsch, E; Ladinek, V; Zloklikovits, S; Stanzer, S; Bauernhofer, T Identifying symptom burden and distress of cancer patients with chemotherapy: A pilot study for an Austrian sample
PSYCHO-ONCOL. ; 15(2):S158-S159. [Poster]
Web of Science

 

** Bauernhofer, T; Samonigg, H; Regitnik, P; Lileg, B; Weizer, W; Waxenecker, G; Kainer, M; Wiederkum, S; Loibner, H; Kircheis, R A phase I/II, open label trial of Lewis Y specific monoclonal antibody IGN311 to evaluate safety and efficacy in patients with malignant effusion.
J CLIN ONCOL. 24(18):111S-111S.-Asco-Meetung; 2.-6. Juni 2006; Atlanta/ Georgia, USA. [Poster]
Web of Science

 

** Dietmaier, G; Ladinek, V; Samonigg, H; Andritsch, E The relation between coping, meaning in life, recurrence and survival and in a sample of Austrian breast cancer patients
PSYCHO-ONCOL. 2006; 15(2):S132-S133.-8th world congress of psycho-oncology; OCT 16-21, 2006; Ferrara-Venice, ITALY. [Oral Communication]
Web of Science

 

** Gerger, A; Horn, M; Samonigg, H; Langsenlehner, U; Krippl, P; Kerl, H; Smolle, J Diagnostic virtual histopathology of untreated fresh specimens from squamous cell carcinoma using confocal laser-scanning microscopy
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France. [Oral Communication]
Web of Science

 

** Gerger, A; Kerl, H; Samonigg, H; Langsenlehner, U; Krippl, P; Smolle, J Sensitivity and specificity of confocal laser scanning microscopy for in vivo diagnosis of malignant skin tumors
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France. [Poster]
Web of Science

 

** Gnant, M; Greil, R; Kubista, E; Menzel, C; Schippinger, W; Seifert, M; Haider, K; Mlineritsch, B; Samonigg, H; Kwasny, W; Fridrik, M; Steger, G; Steindorfer, P; Schmelitsch, J; Poetter, R; Jakesz, R The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine-responsive breast cancer: 10-year results of ABCSG-05 (CMF vs. goserelin plus tamoxifen).
BREAST CANCER RES TREAT. 2006; 100: S10-S11. [Poster]
Web of Science

 

** Ladinek, V; Zloklikovits, S; Adritsch, E; Samonigg, H The observed versus estimated quality of perception of patient symptoms reported by healthcare professionals in palliative care
PSYCHO-ONCOL. 2006; 15(2):S298-S298.-8th world congress of psycho-oncology; OCT 16-21, 2006; Ferrara-Venice, ITALY. [Poster]
Web of Science

 

** Langsenlehner, U; Eder, T; Renner, W; Gerger, A; Hofmann, G; Samonigg, H; Krippl, P The cyclooxygenase-2 (PTGS2) 8473T > C polymorphism increases breast cancer risk.
BREAST CANCER RES TREAT. 2006; 100: S251-S252.-29th Annual San Antonio Breast Cancer Symposium; DEC 14-17, 2006; San Antonio, USA. [Poster]
Web of Science

 

** Loibner, H; Bauernhofer, T; Samonigg, H; Regitnig, P; Weitzer, W; Lileg, B; Waxenecker, G; Kainer, M; Wiederkum, S; Schuster, M; Kircheis, R A phase I/II, open label trial with the Lewis Y specific humanized monoclonal antibody IGN311 in patients with malignant effusions
J IMMUNOTHER. 29(6):634-634.-Meeting Society of Immunotherapy, 21st annual meeting; 26.-29. Oktober 2006; Los Angeles, USA. [Poster]
Web of Science

 

** Samonigg, H Space light, colours. Architectural environment and quality of life in cancer patients
PSYCHO-ONCOL. ; 15(2):S72-S72. [Poster]
Web of Science

 

** Samonigg, H The model of cooperation between the Austrian Society of Haematology and Oncology and the Austrian Association of Psycho-oncology
PSYCHO-ONCOL. ; 15(2):S31-S31. [Oral Communication]
Web of Science

 

** Steger, GG; Greil, R; Samonigg, H; Jakesz, R; Bartsch, R; Mlineritsch, B; Melbinger-Zeinitzer, E; Marth, C; Schippinger, W; Gnant, MF An interim safety analysis of ABCSG-24: 6 cycles of docetaxel, epirubicin, and capecitabine plus pegfilgrastim (DEC) vs. 6 cycles of docetaxel and epirubicin plus pegfilgrastim (DE) in the neoadjuvant treatment of operable breast cancer.
BREAST CANCER RES TREAT. 2006; 100: S156-S156. [Poster]
Web of Science

 

** Zloklikovits, S; Ladinek, V; Andritsch, E; Samonigg, H Symptom assessment in palliative care: A comparison of terminal cancer patients and their family caregivers
PSYCHO-ONCOL. 2006; 15(2):S415-S416.-8th world congress of psycho-oncology; OCT 16-21, 2006; Ferrara-Venice, ITALY. [Poster]
Web of Science

 

2005

Originalarbeit (Zeitschrift)

** Balic, M; Dandachi, N; Hofmann, G; Samonigg, H; Loibner, H; Obwaller, A; van der Kooi, A; Tibbe, AG; Doyle, GV; Terstappen, LW; Bauernhofer, T Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.
Cytometry B Clin Cytom. 2005; 68(1):25-30 Doi: 10.1002/cyto.b.20065 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Bauernhofer, T; Zenahlik, S; Hofmann, G; Balic, M; Resel, M; Pirchmoser, R; Regitnig, P; Ambros, P; Dandachi, N; Samonigg, H Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.
Oncol Rep. 2005; 13(2):179-184
Web of Science PubMed FullText Google Scholar

 

** Dandachi, N; Balic, M; Stanzer, S; Halm, M; Resel, M; Hinterleitner, TA; Samonigg, H; Bauernhofer, T Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.
J Mol Diagn. 2005; 7(5):631-637 Doi: 10.1016/S1525-1578(10)60597-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Filipits, M; Pohl, G; Rudas, M; Dietze, O; Lax, S; Grill, R; Pirker, R; Zielinski, CC; Hausmaninger, H; Kubista, E; Samonigg, H; Jakesz, R Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2005; 23(6):1161-1168 Doi: 10.1200/JCO.2005.03.033 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Jakesz, R; Jonat, W; Gnant, M; Mittlboeck, M; Greil, R; Tausch, C; Hilfrich, J; Kwasny, W; Menzel, C; Samonigg, H; Seifert, M; Gademann, G; Kaufmann, M Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
Lancet. 2005; 366(9484):455-462 Doi: 10.1016/S0140-6736(05)67059-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Eder, T; Köppel, H; Wascher, TC; Paulweber, B; Samonigg, H Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
Breast Cancer Res Treat. 2005; 90(2):113-115 Doi: 10.1007/s10549-004-3607-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Szolar, DH; Korobkin, M; Reittner, P; Berghold, A; Bauernhofer, T; Trummer, H; Schoellnast, H; Preidler, KW; Samonigg, H Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
RADIOLOGY. 2005; 234: 479-485. Doi: 10.1148/radiol.2342031876 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Weber, M; Strohscheer, I; Samonigg, H; Huber, C Palliative sedation--an alternative to euthanasia in intractable pain at the end of life?
Med Klin (Munich). 2005; 100(5): 292-298. Doi: 10.1007/s00063-005-1038-9
Web of Science PubMed FullText FullText_MUG

 

** Zloklikovits, S; Andritsch, E; Fröhlich, B; Verebes, J; Dietmaier, G; Samonigg, H Assessing symptoms of terminally-ill patients by different raters: a prospective study.
Palliat Support Care. 2005; 3(2): 87-98. Doi: 10.1017/S1478951505050169
PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Langsenlehner, U; Hofmann, G; Samonigg, H; Krippl, P; Renner, W; Clar, H Cyclin D1 genotype and breast cancer metastasis.
CANCER EPIDEM BIOMARKER PREV. 2005; 14: 1844-1845. Doi: 10.1158/1055-9965.EPI-05-0204 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Himmler, G; Settaf, A; Groiss, F; Eller, N; Salzberg, M; Kundi, M; Eckert, H; Loibner, H; Samonigg, H A randomized placebo-controlled phase II study with the cancer vaccine candidate IGN101 in patients with epithelial cancers.
J CLIN ONCOL 2005 23: 179S-179S.
Web of Science

 

** Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Wernecke, KD; Samonigg, H; Bauernhofer, T Quantitative measurement of soluble E-cadherin in sera of breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy and its predictive and prognostic value.
J CLIN ONCOL 2005 23: 70S-70S.
Web of Science

 

** Hofmann, G; Langsenlehner, U; Renner, W; Greimel, A; Samonigg, H; Krippl, P Breast cancer metastasis-free survival and its association to a common hereditary gene polymorphism of cyclin D1
BREAST CANCER RES TREAT. 94: S-78-S-79.
Web of Science

 

** Hofmann, G; Langsenlehner, U; Renner, W; Greimel, A; Samonigg, H; Krippl, P A single nucleotide polymorphism in the CCND1 gene is associated with decreased risk of developing metastases in female breast cancer patients
EJC SUPPL. 2005; 3(2): 46-47.
Web of Science

 

** Jakesz, R; Gnant, M; Greil, R; Tausch, C; Samonigg, H; Kwasny, W; Kubista, E; Stierer, M; Luschin, G; Mittlboeck, M The benefits of sequencing adjuvant tamoxifen and anastrozole in postmenopausal women with hormone-responsive early breast cancer: 5 year-analysis of ABCSG Trial 8
BREAST CANCER RES TREAT. 2005; 94: S10-S10.
Web of Science

 

** Jakesz, R; Samonigg, H; Greil, R; Gnant, M; Schmid, M; Kwasny, W; Kubista, E; Mlineritsch, B; Tausch, C; Stierer, M Extended adjuvant treatment with anastrozole: Results from the Austrian breast and colorectal cancer study group trial 6a (ABCSG-6a).
J CLIN ONCOL 2005 23: 10S-10S.
Web of Science

 

** Langsenlehner, U; Eder, T; Weitzer, W; Samonigg, H; Krippl, P The most common integrin ITGA2 haplotype (807C_1648G, wildtype) is associated with decreased breast cancer risk
BREAST CANCER RES TREAT 2005 94: -.
Web of Science

 

** Langsenlehner, U; Krippl, P; Eder, T; Weitzer, W; Samonigg, H Interleukin-10 TCATA haplotype is associated with decreased breast cancer risk
ANN ONCOL 2005 16: 271-271.
Web of Science

 

** Langsenlehner, U; Weitzer, W; Hofmann, G; Eder, T; Samonigg, H; Krippl, R Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk
EJC SUPPL. 2005; 3(2): 84-84.
Web of Science

 

** Samonigg, H; Himmler, G; Gnant, M; Gastl, G; Loibner, H; Possinger, K; Bauernhofer, T; Dandachi, N; Balic, M; Steger, G; Obwaller, A A multicenter phase II, open-label trial of multiple doses of cancer vaccine candidate IGN101 to evaluate efficacy against disseminated tumor cells in blood.
J CLIN ONCOL 2005 23: 180S-180S.
Web of Science

 

2004

Originalarbeit (Zeitschrift)

** Andritsch, E; Goldzweig, G; Samonigg, H; Uziely, B; Ever-Hadani, P; Hoffman, G; Krenn, G; Baider, L Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: a randomized study.
SUPPORT CARE CANCER. 2004; 12(1): 10-18. Doi: 10.1007/s00520-003-0531-z
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Baider, L; Andritsch, E; Goldzweig, G; Uziely, B; Ever-Hadani, P; Hofman, G; Krenn, G; Samonigg, H Changes in psychological distress of women with breast cancer in long-term remission and their husbands.
PSYCHOSOMATICS. 2004; 45(1): 58-68. Doi: 10.1176/appi.psy.45.1.58
Web of Science PubMed FullText FullText_MUG

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Köppel, H; Leithner, A; Wascher, TC; Paulweber, B; Samonigg, H The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Clin Cancer Res. 2004; 10(10):3518-3520 Doi: 10.1158/1078-0432.CCR-04-0010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Samonigg, H The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.
CANCER LETT. 2004; 206(1): 59-62. Doi: 10.1016/j.canlet.2003.11.030
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Eder, T; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
Breast Cancer Res Treat. 2004; 87(1):19-22 Doi: 10.1023/B:BREA.0000041574.90735.ea
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Regitnig, P; Schippinger, W; Lindbauer, M; Samonigg, H; Lax, SF Change of HER-2/neu status in a subset of distant metastases from breast carcinomas.
J PATHOL. 2004; 203(4): 918-926. Doi: 10.1002/path.1592
Web of Science PubMed FullText FullText_MUG

 

** Schippinger, W; Regitnig, P; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Wehrschütz, M; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.
ONCOL REP. 2004; 11(6): 1331-1336. Doi: 10.3892/or.11.6.1331
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schoppmann, SF; Bayer, G; Aumayr, K; Taucher, S; Geleff, S; Rudas, M; Kubista, E; Hausmaninger, H; Samonigg, H; Gnant, M; Jakesz, R; Horvat, R; Austrian Breast and Colorectal Cancer Study Group Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.
ANN SURG. 2004; 240: 306-312. Doi: 10.1097%2F01.sla.0000133355.48672.22 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wolf, G; Aigner, RM; Schaffler, G; Langsenlehner, U; Renner, W; Samonigg, H; Yazdani-Biuki, B; Krippl, P The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake.
BREAST CANCER RES TREAT. 2004; 88(3): 205-208. Doi: 10.1007/s10549-004-0724-2
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Krippl, P; Langsenlehner, U; Samonigg, H; Renner, W; Köppel, H Vascular endothelial growth factor in predicting outcome in breast cancer.
CLIN CANCER RES 2004 10: 8752-8753. Doi: 10.1158/1078-0432.CCR-04-1211 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Korrespondenz

** Krippl, P; Langsenlehner, U; Renner, W; Köppel, H; Samonigg, H Re: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
J NAT CANCER INST. 2004; 96: 1478-1479. Doi: 10.1093/jnci/djh289 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Andritsch, E; Baider, L; Dietmaier, G; Samonigg, H Identifying predictors of quality of life in a randomized sample of breast cancer patients
PSYCHO-ONCOL 2004 13: S154-S155.
Web of Science

 

** Dietmaier, G; Samonigg, H; Andritsch, E Coping with breast cancer - What did help patients and partners most? A pilot study
PSYCHO-ONCOL. 13: S52-S52.-7th World Congress of Psycho-Oncology; AUG 25-28, 2004; Copenhagen, DENMARK.
Web of Science

 

** Gnant, M; Jakesz, R; Mlineritsch, B; Luschin-Ebengreuth, G; Schmid, M; Menzel, C; Kubista, E; Samonigg, H; Hausmaninger, H Zoledronic acid effectively counteracts cancer treatment induced bone loss (CTIBL) in premenopausal breast cancer patients receiving adjuvant endocrine treatment with goserelin plus anastrozole versus goserelin plus tamoxifen - bone density subprotocol results of a randomized multicenter trial (ABCSG-12)
BREAST CANCER RES TREAT. 2004; 88: S8-S9.
Web of Science

 

** Jakesz, R; Kaufmann, M; Gnant, M; Jonat, W; Mittlboeck, M; Greil, R; Tausch, C; Hilfrich, J; Kwasny, W; Samonigg, H Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results from 3,123 women enrolled in the ABCSG trial 8 and the ARNO 95 trial
BREAST CANCER RES TREAT. 2004; 88: S7-S7.
Web of Science

 

** Krippl, P; Langsenlehner, U; Eder, T; Samonigg, H The 5A/6A polymorphism of the stromelysin I gene promotor and breast cancer
BRIT J CANCER 2004 91: S25-S25.
Web of Science

 

** Krippl, P; Langsenlehner, U; Samonigg, H The 825C > T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer
BRIT J CANCER 2004 91: S56-S56.
Web of Science

 

** Langsenlehner, U; Krippl, P; Eder, T; Samonigg, H The SULT1A1 213H variant is associated with the presence of lymph node metastases in breast cancer patients
BRIT J CANCER 2004 91: S26-S26.
Web of Science

 

** Langsenlehner, U; Krippl, P; Samonigg, H The 677C > T polymorphism of methylenetetrahydro folate reductase gene and susceptibility to breast cancer
BRIT J CANCER 2004 91: S26-S26.
Web of Science

 

** Langsenlehner, U; Samonigg, H; Krippl, P The-1377G > A polymorphism in the FAS promoter region is associated with increased breast cancer susceptibility.
BREAST CANCER RES TREAT 2004 88: S72-S72.
Web of Science

 

** Langsenlehner, U; Samonigg, H; Krippl, P Vascular endothelial growth factor gene polymorphism decreases the risk for breast cancer metastasis.
BREAST CANCER RES TREAT 2004 88: S144-S145.
Web of Science

 

** Loibner, H; Eckert, H; Eller, N; Groiss, F; Himmler, G; Rosenkaimer, F; Salzberg, R; Samonigg, H; Schuster, M; Settaf, A A randomized placebo-controlled phase II study with the cancer vaccine IGN101 in patients with epithelial solid organ tumors (IGN101/2-01)
J CLIN ONCOL. 2004; 22(14): 192S-192S.
Web of Science

 

** Schmid, P; Schippinger, W; Nitsch, T; Huebner, G; Kreienberg, R; Schultze, W; Hausmaninger, H; Wischnewsky, M; Samonigg, H; Possinger, K Up-front tandem high-dose chemotherapy (HD) compared to standard chemotherapy with doxorubicin and paclitaxel (AT) in metastatic breast cancer (MBC): Final results of a randomized trial.
J CLIN ONCOL 2004 22: 37S-37S.
Web of Science

 

** Steger, GG; Kubista, E; Hausmaninger, H; Gnant, M; Tausch, C; Lang, A; Samonigg, H; Galid, A; Jakesz, R 6 vs. 3 Cycles of epirubicin/docetaxel plus G-CSF in operable breast cancer: Results of ABCSG-14
J CLIN ONCOL 2004 22: 15S-15S.
Web of Science

 

2003

Originalarbeit (Zeitschrift)

** Baider, L; Andritsch, E; Uziely, B; Ever-Hadani, P; Goldzweig, G; Hofmann, G; Samonigg, H Do different cultural settings affect the psychological distress of women with breast cancer? A randomized study.
Eur J Cancer Care (Engl). 2003; 12(3):263-273 Doi: 10.1046/j.1365-2354.2003.00412.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Bauernhofer, T; Eibl, M; Ploner, F; Kuss, I; Pfeifer, J; Sill, H; Samonigg, H Acute pseudo-obstruction of the small intestine following high-dose chemotherapy and stem cell support.
Onkologie. 2003; 26(4):344-346 Doi: 10.1159/000072093 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Denison, U; Baumann, J; Peters-Engl, C; Samonigg, H; Krippl, P; Lang, A; Obermair, A; Wagner, H; Sevelda, P Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy.
Breast Cancer Res Treat. 2003; 79(3):347-353 Doi: 10.1023/A:1024016508925
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Green, MD; Koelbl, H; Baselga, J; Galid, A; Guillem, V; Gascon, P; Siena, S; Lalisang, RI; Samonigg, H; Clemens, MR; Zani, V; Liang, BC; Renwick, J; Piccart, MJ; International Pegfilgrastim 749 Study Group A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.
Ann Oncol. 2003; 14(1):29-35 Doi: 10.1093/annonc/mdg019 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Jakesz, R; Samonigg, H; Gnant, M; Kubista, E; Depisch, D; Kolb, R; Mlineritsch, B; Mischinger, HJ; Menzel, RC; Steindorfer, P; Kwasny, W; Tausch, C; Stierer, M; Taucher, S; Seifert, M; Hausmaninger, H; Austrian Breast & Colorectal Cancer Study Group Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.
Ann Surg. 2003; 237(4):556-564 Doi: 10.1097/01.SLA.0000059990.43981.4E [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Bahadori, B; Samonigg, H The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk.
Cancer Lett. 2003; 201(2):181-184 Doi: 10.1016/S0304-3835(03)00468-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Haas, J; Samonigg, H A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.
Int J Cancer. 2003; 106(4):468-471 Doi: 10.1002/ijc.11238 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Leithner, A; Samonigg, H The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.
Breast Cancer Res Treat. 2003; 82(3):165-168 Doi: 10.1023/B:BREA.0000004372.20461.33
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk.
Breast Cancer Res Treat. 2003; 81(2):169-172 Doi: 10.1023/A:1025752420309
Web of Science PubMed FullText FullText_MUG

 

** Paridaens, R; Van Aelst, F; Georgoulias, V; Samonigg, H; Cocquyt, V; Zielinski, C; Hausmaninger, H; Willemse, P; Boudraa, Y; Wildiers, J; Ramazeilles, C; Azli, N A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer.
ANN ONCOL. 2003; 14(3): 433-440. Doi: 10.1093/annonc/mdg111 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ploner, F; Jakesz, R; Hausmaninger, H; Kolb, R; Stierer, M; Fridrik, M; Steindorfer, P; Gnant, M; Haider, K; Mlineritsch, B; Tschurtschenthaler, G; Steger, G; Seifert, M; Kubista, E; Samonigg, H; Austrian Breast And Colorectal Cancer Study Group Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients.
Onkologie. 2003; 26(2):115-119 Doi: 10.1159/000069831
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Pohl, G; Rudas, M; Dietze, O; Lax, S; Markis, E; Pirker, R; Zielinski, CC; Hausmaninger, H; Kubista, E; Samonigg, H; Jakesz, R; Filipits, M High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.
J Clin Oncol. 2003; 21(19):3594-3600 Doi: 10.1200/JCO.2003.02.021 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schmid, M; Jakesz, R; Samonigg, H; Kubista, E; Gnant, M; Menzel, C; Seifert, M; Haider, K; Taucher, S; Mlineritsch, B; Steindorfer, P; Kwasny, W; Stierer, M; Tausch, C; Fridrik, M; Wette, V; Steger, G; Hausmaninger, H Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
J Clin Oncol. 2003; 21(6):984-990 Doi: 10.1200/JCO.2003.01.138 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wolf, G; Aigner, RM; Schwarz, T; Krippl, P; Samonigg, H Diagnosis of a contralateral second testicular carcinoma by F18-FDG PET.
Onkologie. 2003; 26(2):155-157 Doi: 10.1159/000069836 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Baider, L; Andritsch, E; Uziely, B; Goldzweig, G; Ever-Hadani, P; Hofman, G; Krenn, G; Samonigg, H Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings.
Crit Rev Oncol Hematol. 2003; 46(1):5-16 Doi: 10.1016/S1040-8428(02)00134-8
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Filipits, M; Pohl, G; Rudas, M; Dietze, O; Lax, S; Pirker, R; Zielinski, CC; Kubista, E; Samonigg, H; Jakesz, R Predictive value of p27KIP1 expression in premenopausal women with early-stage hormone receptor-positive breast cancer.
J CLIN ONCOL 2003 21: 288S-288S.
Web of Science

 

** Krippl, P; Langsenlehner, U; Renner, W; Samonigg, H A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.
BREAST CANCER RES TREAT 2003 82: S140-S140.
Web of Science

 

** Obwaller, A; Balic, M; van der Kooi, A; Dandachi, N; Himmler, G; Mudde, GC; Peball, B; Grunt, S; Oberkleiner, P; Doyle, GV; Terstappen, LWMM; Bauernhofer, T; Samonigg, H; Loibner, H Comparative analysis of three different methods for the detection of disseminated tumor cells
J IMMUNOTHER 2003 26: S49-S50.
Web of Science

 

** Samonigg, H; Hofmann, G; Bauernhofer, T; Balic, M; Stöger, H; Groiss, F; Himmler, G; Schuster, M; Rosenkaimer, F; Loibner, H Phase if trial to explore the influence of concomitant chemotherapies on the immunogenicity of the cancer vaccine IGN101 in patients with epithelial cancers
J IMMUNOTHER 2003 26: S14-S14.
Web of Science

 

** Schippinger, W; Bauernhofer, T; Regitnig, P; Ploner, F; Krippl, P; Hofmann, G; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H Serum HER-2/neu dynamics in metastatic breast cancer as an independent prognostic factor.
BREAST CANCER RES TREAT 2003 82: S123-S123.
Web of Science

 

** Schmid, P; Schippinger, W; Nitsch, T; Huenbner, G; Kreienberg, R; Schultze, W; Hausmaninger, H; Wischnewsky, MB; Luftner, D; Samonigg, H; Possinger, K Up front tandem high-dose chemotherapy compared to standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: updated results of a randomized trial
BREAST CANCER RES TREAT 2003 82: S152-S152.
Web of Science

 

2002

Originalarbeit (Zeitschrift)

** Jakesz, R; Hausmaninger, H; Kubista, E; Gnant, M; Menzel, C; Bauernhofer, T; Seifert, M; Haider, K; Mlineritsch, B; Steindorfer, P; Kwasny, W; Fridrik, M; Steger, G; Wette, V; Samonigg, H; Austrian Breast and Colorectal Cancer Study Group Trial 5 Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
J CLIN ONCOL 2002 20: 4621-4627. Doi: 10.1200%2FJCO.2002.09.112 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Jakesz, R; Hausmaninger, H; Samonigg, H Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer.
Eur J Cancer. 2002; 38(3):327-332 Doi: 10.1016%2FS0959-8049%2801%2900375-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schindl, M; Schoppmann, SF; Samonigg, H; Hausmaninger, H; Kwasny, W; Gnant, M; Jakesz, R; Kubista, E; Birner, P; Oberhuber, G; Austrian Breast and Colorectal Cancer Study Group Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Clin Cancer Res. 2002; 8(6):1831-1837 [OPEN ACCESS]
Web of Science PubMed FullText

 

** Wehrschütz, M; Stöger, H; Ploner, F; Hofmann, G; Wolf, G; Höfler, G; Krippl, P; Samonigg, H Seminoma metastases mimicking primary pancreatic cancer.
Onkologie. 2002; 25(4):371-373 Doi: 10.1159/000066057 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gnant, M; Hausmaninger, H; Samonigg, H; Mlineritsch, B; Taucher, S; Luschin-Ebengreuth, G; Jakesz, R Changes in bone mineral density caused by anastrozole or tamoxifen in combination with goserelin (+/- zoledronate) as adjuvant treatment for hormone receptor-positive premenopausal breast cancer: results of a randomized multicenter trial.
BREAST CANCER RES TREAT. 2002; 76: S31-S31.
Web of Science

 

** Jakesz, R; Hausmaninger, H; Kubista, E; Gnant, M; Seifert, M; Kwasny, W; Steger, G; Samonigg, H; Tausch, C; Stierer, M The prognostic value of HER-2/neu status in premenopausal patients with hormone-responsive breast cancer.
BREAST CANCER RES TREAT. 2002; 76: S44-S44.
Web of Science

 

** Jakesz, R; Samonigg, H; Hausmaninger, H Progesterone receptor quality and level have a significant prognostic and predictive impact in pre- and postmenopausal patients with hormone-responsive breast cancer: six-year results of ABCSG trials 5 and 6.
BREAST CANCER RES TREAT. 2002; 76: S45-S45.
Web of Science

 

** Ploner, F; Genser, B; Schippinger, W; Hofmann, G; Samonigg, H The influence of prognostic factors seems to be constant throughout the course of metastatic breast cancer regardless of therapeutical intervention.
BREAST CANCER RES TREAT. 2002; 76: S48-S48.
Web of Science

 

** Schippinger, W; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Neumann, R; Wernecke, KD; Samonigg, H Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
BREAST CANCER RES TREAT 2002 76: S104-S104.
Web of Science

 

** Strobl, S; Verebes, J; Frohlich, B; Krenn, G; Baumgartner, J; Wernecke, KD; Samonigg, H Prospective evaluation study of a hospital-based palliative care supportive service
J PALLIATIVE CARE 2002 18: 243-243.
Web of Science

 

** Taucher, S; Gnant, M; Hausmaninger, H; Kubista, E; Samonigg, H; Steger, G; Stierer, M; Tausch, C; Jakesz, R The prognostic influence of body mass index in premenopausal breast cancer patients.
BREAST CANCER RES TREAT 2002 76: S50-S50.
Web of Science

 

2001

Originalarbeit (Zeitschrift)

** Birner, P; Oberhuber, G; Stani, J; Reithofer, C; Samonigg, H; Hausmaninger, H; Kubista, E; Kwasny, W; Kandioler-Eckersberger, D; Gnant, M; Jakesz, R; Austrian Breast & Colorectal Cancer Study Group Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.
Clin Cancer Res. 2001; 7(6):1669-1675 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

** Latinovic, L; Heinze, G; Birner, P; Samonigg, H; Hausmaninger, H; Kubista, E; Kwasny, W; Gnant, M; Jakesz, R; Oberhuber, G; Austrian Breast and Colorectal Cancer Study Group Prognostic relevance of three histological grading methods in breast cancer.
Int J Oncol. 2001; 19(6):1271-1277 Doi: 10.3892/ijo.19.6.1271
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Andritsch, E; Baider, L; Samonigg, H; Uziely, B; Ever-Hadani, P; Hofmann, G; Goldzweig, G Psychological distress in a sample of breast cancer women: a cross-cultural study between Graz and Jerusalem
PSYCHO-ONCOL 2001 10: B085-B085.
Web of Science

 

Originalarbeit (Konferenzband)

** Kronberger, L; Wagner, P; Puchinger, M; Stranzl, H; Lax, SF; Kohek, P; Linck, FG; Schippinger, W; Thalhammer, M; Rigler, N; Hoss, G; Samonigg, H; Mischinger, HJ; Kapp, K; Rehak, P; Smola, M Radiofrequency-hyperthermia in combination with chemo- and radiotherapy in palliative treatment of breast cancer - A case report
In: Mozzillo, N, Parisi, V. editors(s). 2ND CANCER SYMPOSIUM - SELECTED FREE PAPERS; 17-21. (ISBN: 88-323-1919-5) ( Presented at: 2nd Cancer Symposium, NAPLES, ITALY, SEP 19-22, 2001)
Web of Science

 

2000

Abstract (Zeitschrift)

** Kuss, I; Wagner, P; Genser, B; Stöger, H; Kasparek, AK; Samonigg, H Low dose weekly anthracycline chemotherapy for breast cancer patients with bone marrow infiltration.
ANN ONCOL 2000 11: 38-38.
Web of Science

 

1999

Originalarbeit (Zeitschrift)

** Hausmaninger, H; Moser, R; Samonigg, H; Mlineritsch, B; Schmidt, H; Pecherstorfer, M; Fridrik, M; Kopf, C; Nitsche, D; Kaider, A; Ludwig, H Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III study.
Eur J Cancer. 1999; 35(3):380-385 Doi: 10.1016%2FS0959-8049%2898%2900397-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Jakesz, R; Hausmaninger, H; Haider, K; Kubista, E; Samonigg, H; Gnant, M; Manfreda, D; Tschurtschenthaler, G; Kolb, R; Stierer, M; Fridrik, M; Mlineritsch, B; Steindorfer, P; Mittlböck, M; Steger, G Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
J Clin Oncol. 1999; 17(6):1701-1709 Doi: 10.1200/JCO.1999.17.6.1701 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kucera, E; Speiser, P; Gnant, M; Szabo, L; Samonigg, H; Hausmaninger, H; Mittlböck, M; Fridrik, M; Seifert, M; Kubista, E; Reiner, A; Zeillinger, R; Jakesz, R Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Austrian Breast Cancer Study Group.
Eur J Cancer. 1999; 35(3):398-405 Doi: 10.1016/S0959-8049(98)00400-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Samonigg, H; Wilders-Truschnig, M; Kuss, I; Plot, R; Stöger, H; Schmid, M; Bauernhofer, T; Tiran, A; Pieber, T; Havelec, L; Loibner, H A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.
J Immunother. 1999; 22(6):481-488 Doi: 10.1097/00002371-199911000-00002
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Reisinger, EC; Schmid, M; Simbrunner, J; Samonigg, H; Eustacchio, S; Pendl, G Gamma knife radiosurgery in cerebral echinococcosis - Reply.
CLIN INFECT DIS . 1999; 28(2): 409-409. Doi: 10.1086/517207 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Bauernhofer, T; Stöger, H; Kasparek, AK; Ploner, F; Kuss, I; Pieber, TR; Kotz, R; Samonigg, H Combined treatment of metastatic osteosarcoma of the spine.
Oncology. 1999; 57(4):265-268 Doi: 10.1159/000012058 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Andritsch, E; Samonigg, H An integrated psychological care model on the grazer university oncology institution
PSYCHO-ONCOL 1999 8: 53-53.
Web of Science

 

** Bauernhofer, T; Schmid, M; Resel, M; Gilli, R; Halwachs, G; Lanzer, G; Wilders-Truschnig, M; Samonigg, H Detection of minimal residual disease in bone marrow (BM) peripheral blood (PB) and apheresis products (AP) in metastatic breast cancer patients receiving sequential dose intensive chemotherapy with PBPC support.
BONE MARROW TRANSPLANT 1999 23: S145-S145.
Web of Science

 

** Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science

 

** Jakesz, R; Hausmaninger, H; Samonigg, H; Kubista, E; Depisch, D; Fridrik, M; Stierer, M; Gnant, M; Steger, G; Kolb, R; Jatzko, G; Hofbauer, F; Reiner, G; Steindorfer, P Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: Four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5
EUR J CANCER. 1999; 35: S83-S83. Doi: 10.1016/S0959-8049(99)80701-1
Web of Science FullText FullText_MUG

 

** Samonigg, H; Kuss, I; Bauernhofer, T; Andritsch, E The influence of an artistic design at an oncological ward on the patients' mood
PSYCHO-ONCOL 1999 8: 41-41.
Web of Science

 

** Schmid, M; Bauernhofer, T; Resel, M; Ploner, F; Schippinger, W; Gilli, R; Lanzer, G; Truschnig-Wilders, M; Samonigg, H High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
BONE MARROW TRANSPLANT 1999 23: S42-S42.
Web of Science

 

1998

Originalarbeit (Zeitschrift)

** Jakesz, R; Hausmaninger, H; Samonigg, H; Kubista, E; Haider, K; Mlineritsch, B; Schmid, M; Tausch, C; Reiner, G; Renner, K; Stierer, M; Jatzko, G; Hofbauer, F; Fridrik, M; Schennach, W; Sevelda, P; Dadak, C; Haid, A; Scholz, R; Lenzhofer, P; Steindorfer, P; Berger, A; Mischinger, HJ Therapy studies of the Austrian Breast Cancer Group (ABC).
Zentralbl Chir. 1998; 123 Suppl 5:28-32
Web of Science PubMed

 

** Jakesz, R; Samonigg, H; Gnant, M; Kubista, E; Steindorfer, P; Hausmaninger, H; Sevelda, P; Tschurtschenthaler, B; Fridrik, M; Stierer, M; Kolb, R; Steger, G Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study Group.
Eur J Cancer. 1998; 34(1):66-70 Doi: 10.1016/S0959-8049(97)10010-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Lackner, C; Moser, R; Bauernhofer, T; Wilders-Truschnig, M; Samonigg, H; Berghold, A; Zatloukal, K Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
Breast Cancer Res Treat. 1998; 47(1):29-40 Doi: 10.1023%2FA%3A1005913514376
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schmid, M; Pendl, G; Samonigg, H; Ranner, G; Eustacchio, S; Reisinger, EC Gamma knife radiosurgery and albendazole for cerebral alveolar hydatid disease.
Clin Infect Dis. 1998; 26(6):1379-1382 Doi: 10.1086/516351 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stöger, H; Samonigg, H; Krainer, M; Ploszczynski, M; Nirnberger, G; Maca, S; Hehenwarter, W; Wirth, M; Schüller, J; Vavra, N; Scheithauer, W; Kornek, G; Stierer, M; Zielinski, CC Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor.
Eur J Cancer. 1998; 34(4):482-488 Doi: 10.1016/S0959-8049(97)10039-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Abstract (Zeitschrift)

** vonMinckwitz, G; Heidemann, E; Souchon, R; Samonigg, H; Hirschmann, WD; Bodenstein, H; Schindler, A; Schulze, M; Clemens, H; Konig, M; Scharl, A; Fischer, JT; Kaufmann, M Mitoxantrone (N) vs. 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as first line therapy in high-risk metastatic breast cancer
EUR J CANCER 1997 33: 646-646.
Web of Science

 

1996

Übersichtsarbeit

** Bauernhofer, T; Stöger, H; Schmid, M; Smola, M; Gürtl-Lackner, B; Höfler, G; Ranner, G; Reisinger, E; Samonigg, H Sequential treatment of recurrent mesenteric desmoid tumor.
Cancer. 1996; 77(6):1061-1065 Doi: 10.1002/(SICI)1097-0142(19960315)77:6<1061::AID-CNCR9>3.0.CO;2-K (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1995

Originalarbeit (Zeitschrift)

** Hausmaninger, H; Lehnert, M; Steger, G; Sevelda, P; Tschurtschenthaler, G; Hehenwarter, W; Fridrik, M; Samonigg, H; Schiller, L; Manfreda, D Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer.
Eur J Cancer. 1995; 31A(13-14):2169-2173 Doi: 10.1016%2F0959-8049%2895%2900489-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ludwig, H; Sundal, E; Pecherstorfer, M; Leitgeb, C; Bauernhofer, T; Beinhauer, A; Samonigg, H; Kappeler, AW; Fritz, E Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
CANCER 1995 76: 2319-2329. Doi: 10.1002/1097-0142(19951201)76:11<2319::AID-CNCR2820761121>3.0.CO;2-U [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Moser, R; Hausmaninger, H; Ludwig, H; Fridrik, M; Schmidt, H; Mlineritsch, B; Pecherstorfer, M; Michlmayr, G; Kopf, C; Samonigg, H 5-Fluorouracil and Folinic Acid with or Without Alpha-2C Interferon in the Treatment of Metastatic Colorectal-Cancer - Preliminary-Results of a Multicenter Prospective Randomized Phase-III Trial
ONKOLOGIE 1995 18: 131-135. Doi: 10.1159/000218573
Web of Science FullText FullText_MUG

 

** Pakisch, B; Stöger, H; Poschauko, H; Samonigg, H; Bauernhofer, T; Pojer, E; Leitner, H; Stuecklschweiger, G; Peichl, KH; Quehenberger, F; Hackl, A Treatment Results in Males with Breast-Cancer
EUROPEAN RADIOL. 1995; 5: 172-175. Doi: 10.1007/BF00957114
Web of Science FullText FullText_MUG

 

** Schmid, M; Samonigg, H; Stöger, H; Auer, H; Sternthal, MH; Wilders-Truschnig, M; Reisinger, EC Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: case report.
Clin Infect Dis. 1995; 20(6):1543-1546 Doi: 10.1093/clinids/20.6.1543 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** LUDWIG, H; FRITZ, E; LEITGEB, C; PECHERSTORFER, M; SAMONIGG, H; SCHUSTER, J ERYTHROPOIETIN FOR CHRONIC ANEMIA OF CANCER - TREATMENT RESULTS AND PREDICTION OF RESPONSIVENESS
EUR J CANCER 1995 31A: 7-7.
Web of Science

 

** SAMONIGG, H; WILDERSTRUSCHNIG, M; KUSS, I; PLOT, R; STOGER, H; SCHMID, M; BAUERNHOFER, T; TIRAN, A; HAVELEC, L; LOIBNER, H IMMUNIZATION WITH ANTIIDIOTYPE VACCINE SCV-106 PROLONGS SURVIVAL-TIME OF CANCER-PATIENTS WITH METASTATIC COLORECTAL-CANCER - A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL
EUR J CANCER 1995 31A: 45-45.
Web of Science

 

1994

Originalarbeit (Zeitschrift)

** Ludwig, H; Fritz, E; Leitgeb, C; Pecherstorfer, M; Samonigg, H; Schuster, J Prediction of response to erythropoietin treatment in chronic anemia of cancer.
Blood. 1994; 84(4):1056-1063 Doi: 10.1182/blood.V84.4.1056.bloodjournal8441056 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stöger, H; Bauernhofer, T; Kasparek, AK; Schmid, M; Moser, R; Ploner, F; Derstvenscheg, E; Kuss, I; Wilders-Truschnig, M; Steindorfer, P Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Cancer Chemother Pharmacol. 1994; 34(1):75-78 Doi: 10.1007/BF00686116
Web of Science PubMed FullText FullText_MUG

 

** Stöger, H; Bauernhofer, T; Moser, R; Derstvenscheg, E; Schmid, M; Ploner, F; Pakisch, B; Wilders-Truschnig, M; Haas, J; Steindorfer, P Breast cancer in the man: a report of 30 patients].
Wien Klin Wochenschr. 1994; 106(18):575-580
Web of Science PubMed Google Scholar

 

** Stöger, H; Bauernhofer, T; Schmid, M; Ploner, F; Moser, R; Derstvenscheg, E; Steindorfer, P; Wilders-Truschnig, M; Kuss, I; Samonigg, H A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Cancer Chemother Pharmacol. 1994; 35(2):174-178 Doi: 10.1007/BF00686643
Web of Science PubMed FullText FullText_MUG

 

** Stöger, H; Schmid, M; Bauernhofer, T; Moser, R; Ploner, F; Derstvenscheg, E; Kasparek, AK; Kuss, I; Wilders-Truschnig, M; Lackner, C A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer.
Oncology. 1994; 51(6):518-522 Doi: 10.1159/000227397
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stöger, H; Wilders-Truschnig, M; Schmid, M; Petek, W; Samonigg, H Scurvy after a suicide attempt by starvation].
Dtsch Med Wochenschr. 1994; 119(16):589-592 Doi: 10.1055/s-2008-1058734 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Zweiker, R; Eber, B; Samonigg, H; Reisinger, EC; Kasparek, A; Schumacher, M; Fruhwald, FM; Apfelbeck, U; Klein, W Toxoplasmosis peri-myocarditis as initial manifestation of highly malignant non-Hodgkin's lymphoma
Z Kardiol. 1994; 83(3):234-237 (- Case Report)
Web of Science PubMed

 

Kurzbericht/Note

** Silly, H; Wilderstruschnig, M; Brezinschek, R; Brezinschek, HP; Schmid, M; Kuss, I; Mucher, K; Stöger, H; Samonigg, H Varying Amounts of Tumor-Cells in the Bone-Marrow of Patients with Nonmetastatic Colorectal-Cancer
ONKOLOGIE. 1994; 17: 184-186. Doi: 10.1159/000218406
Web of Science FullText FullText_MUG

 

1993

Originalarbeit (Zeitschrift)

** Stöger, H; Wilders-Truschnig, M; Samonigg, H; Schmid, M; Bauernhofer, T; Tiran, A; Tas, M; Drexhage, HA The presence of immunosuppressive 'p15E-like' factors in the serum and urine of patients suffering from malign and benign breast tumours.
Clin Exp Immunol. 1993; 93(3):437-441 Doi: 10.1111/j.1365-2249.1993.tb08197.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Smola, MG; Ratschek, M; Amann, W; Samonigg, H; Mayer, R The impact of resection margins in the treatment of primary sarcomas of the breast. A clinicopathological study of 8 cases with review of literature.
Eur J Surg Oncol. 1993; 19(1):61-69
PubMed Google Scholar

 

1992

Originalarbeit (Zeitschrift)

** Samonigg, H; Wilders-Truschnig, M; Loibner, H; Plot, R; Rot, A; Kuss, I; Werner, G; Stöger, H; Wrann, M; Herlyn, D Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody.
Clin Immunol Immunopathol. 1992; 65(3):271-277 Doi: 10.1016/0090-1229(92)90157-J (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Smolle-Juettner, FM; Pinter, H; Smolle, J; Pakisch, B; Arian-Schad, K; Samonigg, H; Jeran, H; Friehs, G; Hackl, A Surgical and non-surgical treatment of cancer of the oesophagus and the oesophagogastric junction: results of 200 consecutive cases.
Wien Klin Wochenschr. 1992; 104(18):563-569
Web of Science PubMed Google Scholar

 

Kurzbericht/Letter

** Silly, H; Samonigg, H; Stöger, H; Brezinschek, HP; Wilders-Truschnig, M Micrometastatic tumour cells in bone marrow in colorectal cancer.
Lancet. 1992; 340(8830):1288-1288 Doi: 10.1016/0140-6736(92)92987-Q
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1991

Originalarbeit (Zeitschrift)

** Samonigg, H; Stöger, H; Kasparek, AK; Schmid, M; Dusleag, J; Pfeiffer, K; Smola, M; Steindorfer, P; Lechner, P Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Cancer Chemother Pharmacol. 1991; 27(6):477-480 Doi: 10.1007/BF00685163
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Originalarbeit (Zeitschrift)

** Samonigg, H; Kasparek, AK; Stöger, H; Schmid, M; Eber, B; Stark, G; Weinrauch, V; Pfeiffer, K; Smola, M; Steindorfer, P 4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.
Cancer Chemother Pharmacol. 1990; 26(4):293-296 Doi: 10.1007/BF02897233
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Samonigg, H; Stöger, H; Bauernhofer, T; Schmid, M; Kasparek, AK; Kuss, I; Kaul, M; Heberle, U; Vieder, L; Dusleag, J Combination therapy of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose folinic acid in patients with advanced breast cancer: a phase I-II study (preliminary results).
Am J Clin Oncol. 1990; 13 Suppl 1(4):S44-S47 Doi: 10.1097/00000421-199012001-00010
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Scheithauer, W; Samonigg, H; Depisch, D; Schüller, J; Hausmaninger, H; Wiegele, J; Zielinsky, C; Stöger, H; Haider, K; Preis, P Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II study.
Invest New Drugs. 1990; 8(2):207-210 Doi: 10.1007/BF00177262
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stark, G; Stark, U; Samonigg, H; Kasparek, K; Lueger, A; Nagl, S; Bertuch, H; Pilger, E; Tritthart, HA Comparison of acute effects of anthracyclines on cardiac electrophysiological parameters of isolated guinea-pig hearts.
Cancer Chemother Pharmacol. 1990; 26(6):415-418 Doi: 10.1007/BF02994091
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Loibner, H; Plot, R; Rot, A; Werner, G; Wrann, M; Samonigg, H; Schmid, M; Stöger, H; Truschnig, M; Herlyn, D Immunoreactivity of patient with colorectal cancer metastasis after immunisation with anti-idiotypes.
Lancet. 1990; 335(8682):171-171 Doi: 10.1016/0140-6736(90)90044-6 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1989

Originalarbeit (Zeitschrift)

** Hausmaninger, H; Lehnert, M; Steger, G; Sevelda, P; Michlmayr, G; Hehenwarter, W; Fridrik, M; Samonigg, H; Schiller, L; Manfreda, D Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancer.
Onkologie. 1989; 12(5):225-229 Doi: 10.1159/000216651
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1988

Originalarbeit (Zeitschrift)

** Samonigg, H; Hossfeld, DK; Spehn, J; Fill, H; Leb, G Aclarubicin in advanced thyroid cancer: a phase II study.
Eur J Cancer Clin Oncol. 1988; 24(8):1271-1275 Doi: 10.1016/0277-5379(88)90214-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** SAMONIGG, H; SCHEITHAUER, W; DEPISCH, D; WIEGELE, J; SCHULLER, J; HAUSMANNINGER, H; LUDWIG, H; STOGER, H; PREIS, P; KASPAREK, AK; ZIELINSKI, C PHASE-II STUDY - PIRARUBICIN (4-O-TETRAHYDRO-PYRANYL-ADRIAMYCIN THP) IN ADVANCED BREAST-CANCER
BLUT. 1988; 57(4): 206-206.
Web of Science

 

** STARK, G; STARK, U; SAMONIGG, H; KASPAREK, K; BERTUCH, H; HONIGL, K; PILGER, E; STOGER, H; TRITTHART, HA THE INFLUENCE BY ADRIBLASTIN AND PIRARUBICIN ON CARDIAC ELECTRICAL-ACTIVITY
BLUT. 1988; 57(4): 202-202.
Web of Science

 

1987

Originalarbeit (Zeitschrift)

** Petritsch, W; Pristautz, H; Eber, B; Schreiber, F; Stauber, R; Samonigg, H; Fereberger, W Pathologic enzyme patterns in sonographically verified liver metastases.
Wien Med Wochenschr. 1987; 137(24):582-584
Web of Science PubMed

 

** Simader, H; Hausmaninger, H; Fereberger, W; Samonigg, H Combination chemotherapy with aclarubicin in metastatic breast cancer.
Eur J Haematol Suppl. 1987; 47:71-76 Doi: 10.1111/j.1600-0609.1987.tb00027.x
PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** SAMONIGG, H; STOGER, H; KASPAREK, AK A PHASE-II-STUDY - COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER WITH MITOXANTRONE, 5-FLUOROURACIL AND PREDNIMUSTINE
BLUT. 1987; 55(4): 362-362.
Web of Science

 

** STOGER, H; KASPAREK, AK; SAMONIGG, H PREOPERATIVE POLYCHEMOTHERAPY WITH MITOXANTRONE, 5-FLUOROURACIL AND PREDNIMUSTINE FOR INFLAMMATORY BREAST-CANCER
BLUT. 1987; 55(4): 363-363.
Web of Science

 

1986

Abstract (Zeitschrift)

** SAMONIGG, H; LEB, G; SPEHN, J; HOSSFELD, D; FILL, H METASTASIZING THYROID-CARCINOMA - THERAPY WITH ACLARUBICIN
ACTA MED AUST. 1986; 13: 96-97.
Web of Science

 

1985

Originalarbeit (Zeitschrift)

** Samonigg, H Value of hormone therapy in metastasizing breast cancer
WIEN MED WOCHENSCHR. 1985; 135(23-24): 602-607.
Web of Science PubMed

 

Abstract (Zeitschrift)

** SAMONIGG, H; LEB, G; GOEBEL, R; BIFFL, E THE VALUE OF LAMIN IN P-1 AS TUMOR-MARKERS IN METASTASIZING MAMMARY-CANCER
ACTA MED AUST. 1985; 12: 63-64.
Web of Science

 

1984

Originalarbeit (Zeitschrift)

** Fereberger, W; Neubauer, M; Samonigg, H; Schenk, H Emergencies in oncology
WIEN MED WOCHENSCHR. 1984; 134(13-14): 336-339.
Web of Science PubMed

 

** Samonigg, H; Fereberger, W; Biffl, E Pneumatic cold cap for the prevention of doxorubicin-induced alopecia
WIEN MED WOCHENSCHR. 1984; 134(21): 467-470.
Web of Science PubMed Google Scholar

 

** Sterz, F; Borkenstein, J; Samonigg, H Endogenous creatinine clearing during cytostatic therapy
WIEN MED WOCHENSCHR. 1984; 134(22): 499-504.
Web of Science PubMed

 

Abstract (Zeitschrift)

** FEREBERGER, W; SAMONIGG, H; MOROZ, C FERRITIN-BEARING LYMPHOCYTES AS A DIAGNOSTIC-TOOL IN BREAST-CANCER PATIENTS
BLUT. 1984; 49(3): 261-262.
Web of Science

 

1983

Abstract (Zeitschrift)

** SAMONIGG, H; FEREBERGER, W; LEB, G; BIFFL, E ACLACINOMYCIN THERAPY IN METASTASIZING THYROID-CANCER
BLUT. 1983; 47(3): 175-176.
Web of Science

 

** SAMONIGG, H; LEB, G; GOEBEL, R; FEREBERGER, W; BIFFL, E ACLACINOMYCIN-A, A NEW CYTOSTATIC AGENT IN THE TREATMENT OF THYROID-CARCINOMA
ACTA ENDOCRINOL. 1983; 102: 77-78.
Web of Science

 

1982

Originalarbeit (Zeitschrift)

** Fereberger, W; Leb, G; Passath, A; Samonigg, H; Beaufort, F Immunoreactive serum calcitonin in breast cancer
MUNCHEN MED WOCHENSCHR. 1982; 124(19): 471-472.
Web of Science PubMed

 

** Samonigg, H; Fereberger, W; Steindorfer, P Clinical features and therapeutic management of male breast cancer (author's transl)
Wien Klin Wochenschr. 1982; 94(7):172-176
Web of Science PubMed Google Scholar

 

Abstract (Zeitschrift)

** FEREBERGER, W; SAMONIGG, H; NEUBAUER, M; BIFFL, E ACLACINOMYCIN-A IN SOLID TUMORS - PRELIMINARY-RESULTS OF A PHASE-II TRIAL
BLUT. 1982; 45(3): 182-183.
Web of Science

 

1981

Originalarbeit (Zeitschrift)

** Fereberger, W; Leb, G; Goebel, R; Samonigg, H; Robier, FP The current status of scintigraphy in oncology (author's transl)
ACTA MED AUST. 1981; 8(3): 88-92.
Web of Science PubMed

 

Abstract (Zeitschrift)

** FEREBERGER, W; LEB, G; PASSATH, A; SAMONIGG, H; BEAUFORT, F SERUM CALCITONIN LEVEL IN CASES OF BREAST-CANCER
ACTA MED AUST. 1981; 8: 190-190.
Web of Science

 

** SAMONIGG, H; FEREBERGER, W; LANZER, G; NEUBAUER, M DIURNAL FLUCTUATIONS IN IMMUNOGLOBULINS AND PARAPROTEINS
ACTA MED AUST. 1981; 8: 198-198.
Web of Science

 

** SAMONIGG, H; FEREBERGER, W; STEINDORFER, P TREATMENT OF BREAST-CANCER IN MEN
ACTA MED AUST. 1981; 8: 198-198.
Web of Science

 

** SOMMERSGUTTER, M; SAMONIGG, H; FEREBERGER, W; ZANGGER, J THE INFLUENCE OF LOCAL APPLICATION OF 5-FLUOROURACIL ON THE NORMAL BRONCHIAL AND ALVEOLAR EPITHELIUM OF THE RAT
ACTA MED AUST. 1981; 8: 200-201.
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum